Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
SEMICONDUCTOR MATERIALS PREPARED FROM BRIDGED BITHIAZOLE COPOLYMERS
Document Type and Number:
WIPO Patent Application WO/2012/016925
Kind Code:
A2
Abstract:
The present invention provides semiconducting compounds, oligomers and polymers of formula wherein A1 and A2 can be the same or different and are S or Se, E is selected from the group consisting of The compounds, oligomers and polymers of formula of formula (1) are suitable for use in electronic devices such as organic field effect transistors.

Inventors:
MISHRA ASHOK KUMAR (SG)
VAIDYANATHAN SUBRAMANIAN (SG)
NOGUCHI HIROYOSHI (SG)
DOETZ FLORIAN (SG)
ZHU BO (CN)
BASUKI JOHAN SEBASTIAN (AU)
Application Number:
PCT/EP2011/063109
Publication Date:
February 09, 2012
Filing Date:
July 29, 2011
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BASF SE (DE)
POLYERA CORP (US)
MISHRA ASHOK KUMAR (SG)
VAIDYANATHAN SUBRAMANIAN (SG)
NOGUCHI HIROYOSHI (SG)
DOETZ FLORIAN (SG)
ZHU BO (CN)
BASUKI JOHAN SEBASTIAN (AU)
International Classes:
C08G61/12
Domestic Patent References:
WO2009069687A12009-06-04
Foreign References:
EP2085401A12009-08-05
US20080121281A12008-05-29
Other References:
FUCHIGAMI, H., TSUMURA, A., KOEZUKA, H., APPL. PHYS. LETT., vol. 63, 1993, pages 1372 - 1374
BAO, Z., DOBADALAPUR, A, LOVINGER, A., J. APPL. PHYS. LETT., vol. 69, 1996, pages 4108 - 4110
J. AM. CHEM. SOC., vol. 129, 2007, pages 3472 - 3473
XIAO, S, ZHOU H., YOU, W., MACROMOLECULES, vol. 41, 2008, pages 5688 - 5696
SCHARBER, M. C., KOPPE, M., GAO, J., CORDELLA, F., LOI, M. A., DENK, P., MORANA, M., EGELHAAF, H.-J., FORBERICH, K., DENNLER, G., J. ADV. MATER., vol. 21, 2009, pages 1 - 4
RIEGER, R., BECKMANN, D., PISULA, W., STEFFEN, W., KASTLER, M., MULLEN K., ADV. MATER., vol. 22, 2010, pages 83 - 86
KIM, D. H., LEE, B.-L, MOON, H., KANG, H. M., JEONG, E. J., PARK, J., HAN, K.-M., LEE, S., YOO, B. W., KOO, B. W., Z. J. AM. CHEM. SOC., vol. 131, 2009, pages 6124 - 6132
OSAKA, I., SAUVE, G., ZHANG, R., KOWALEWSKI, T., MCCULLOUGH R. D., ADV. MATER., vol. 19, 2007, pages 4160 - 4165
LANDQUIST, J. K. J., CHEM. SOC. C, 1967
GREEN, A.G., J. CHEM. SOC., TRANS., vol. 83, 1903, pages 1201 - 1212
COX, RJ., CLECAK, N.J., J. ORG. CHEM., vol. 33, 1968, pages 2132 - 2133
Attorney, Agent or Firm:
LINDNER, Anton (- IP Department -P.O. Box, Basel, CH)
Download PDF:
Claims:
Claims

1 . A compound, oligomer or polymer of formula wherein

A1 and A2 can be the same or different and are S or Se, E is selected from the group consisting of wherein

R1 and R2 can be the same or different and are H, halogen, -CN , Ci-30-alkyl, C2-3o-alkenyl, C2-2o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, Ce-io-cycloalkynyl, Ci-3o-haloalkyl, monovalent 3 to 12 membered aliphatic heterocyclic residue, -X1-R6, -X2-Ar1, -X2-Ar2-Ar1, -X2-Ar2-R7 or -X2-Ar2-Ar3-R7,

wherein

X1 at each occurrence is independently -0-, -[Z1-0]a-, -[0-Z1]a-0-, -S-, -[Z1-S-]a-, -[S-Z1]a-S-, -S(O), -C(O)-, -C(0)0-, -C(0)NR8-, C(0)S-, -O(CO)-, -S(CO)-, -NR8C(0)- or -NR8-,

wherein

Z1 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or Ci-6-haloalkylene,

a at each occurrence is independently an integer from 1 to 10 and

R8 at each occurrence is independently H, Ci-20-alkyl, or -Z2-C6-i4-aryl, wherein

Z2 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

R6 at each occurrence is independently Ci-30-alkyl, C2-3o-alkenyl or Ci-30-haloalkyl,

X2 at each occurrence is independently -Z3-0-Z4-, -Z3-S-Z4-, -S(O)-, -C(O)-, -C(0)0-, -(CO)NR9, -C(0)S-, -O(CO)-, -S(CO)-, -NR9C(0)-, -NR9-, -Z3-SiR92-Z4-, Ci-3o-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a covalent bond,

wherein

Z3 and Z4 at each occurrence are independently Ci-6-alkylene, C2-6-alkenyl- ene, Ci-6-haloalkylene or a covalent bond, and R9 at each occurrence is independently H, Ci-20-alkyl, or -Z5-C6-i4-aryl, wherein

Z5 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

Ar1 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 sub- stituents Ra, wherein each Ra is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar2 and Ar3 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents Rb, wherein each Rb is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R7 at each occurrence is independently Ci-20-alkyl, C2-2o-alkenyl, Ci-20-haloalkyl, Ci-2o-alkoxy, -X3-Ar4, -X3-Ar5-Ar4, -X3-Ar5-R10, or -XS-ArS-Are-R10,

wherein

X3 at each occurrence is independently -Z6-0-Z7-, -Z6-S-Z7, -S(O)-, -C(O)-, -C(0)0-, -(CO)NR11, -C(0)S-, -O(CO)-, -S(CO)-, -NR11C(0)-, -NR11-,

-Z6-SiR1 12-Z7-, Ci-3o-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a covalent bond,

wherein

Z6 and Z7 at each occurrence are independently Ci-6-alkylene,

C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and

R11 at each occurrence is independently H , Ci-20-alkyl or -Z8-C6-i4-aryl, wherein

Z8 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

Ar4 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents Rc, wherein each Rc is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar5 and Ar6 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents Rd, wherein each Rd is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R10 at each occurrence is independently Ci-20-alkyl, C2-2o-alkenyl,

Ci-2o-haloalkyl or Ci-20-alkoxy, R3, R4 and R5 can be the same or different and are H, halogen, -CN , Ci-30-alkyl, C2-3o-alkenyl, C2-2o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, Ce-io-cycloalkynyl, Ci-3o-haloalkyl, monovalent 3 to 12 membered aliphatic heterocyclic residue, -X4-R12, -X5-Ar7, -X5-Ar8-Ar7, -X5-Ar8-R13 or -X5-Ar8-Ar9-R13,

wherein

X4 at each occurrence is independently -[Z9-0]b-, -[Z9-S-]b-, -S(O)-, -C(O)-, -C(0)0-, -C(0)NR14- or C(0)S-,

wherein

Z9 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or Ci-6-haloalkylene,

b at each occurrence is independently an integer from 1 to 10 and

R14 at each occurrence is independently H, Ci-20-alkyl, or -Z10-C6-i4-aryl, wherein

Z10 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

R12 at each occurrence is independently Ci-30-alkyl, C2-3o-alkenyl or Ci-3o-haloalkyl,

X5 at each occurrence is independently -Z11-0-Z12, -Z11-S-Z12-, -S(O)-, -C(O)-, -C(0)0-, -(CO)NR15, -C(0)S-, -Z11-SiR152-Z12-, Ci-30-alkylene, C2-30-alkenylene, Ci-3o-haloalkylene or a covalent bond,

wherein

Z11 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or Ci-6-haloalkylene,

Z12 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and

R15 at each occurrence is independently H, Ci-20-alkyl, or -Z13-C6-i4-aryl, wherein

Z13 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

Ar7 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents Re, wherein each Re is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar8 and Ar9 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents Rf, wherein each Rf is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl and R13 at each occurrence is independently Ci-20-alkyl, C2-2o-alkenyl, Ci-20-haloalkyl, Ci-2o-alkoxy, -X6-Ar10, -X6-Ar11-Ar10, -X6-Ar11-R16, or -X6-Ar11-Ar12-R17,

wherein

X6 at each occurrence is independently -Z14-0-Z15-, -Z14-S-Z15, -S(O)-, -C(O)-, -C(0)0-, -(CO)NR18, -C(0)S-, -O(CO)-, -S(CO)-, -N R18C(0)-, -N R18-,

-Z14-SiR182-Z15-, Ci-3o-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a cova- lent bond,

wherein

Z14 and Z15 at each occurrence are independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and

R18 at each occurrence is independently H, Ci-2o-alkyl or -Z16-C6-i4-aryl, wherein

Z16 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

Ar10 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 sub- stituents Rs, wherein each Ra is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar11 and Ar12 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents Rh, wherein each Rh is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl and

R17 at each occurrence is independently Ci-2o-alkyl, C2-2o-alkenyl, Ci-20-haloalkyl or Ci-2o-alkoxy,

R19 is O or C(CN)2, and

R20 and R21 are the same or different and are R22 or CN,

wherein R22 has the same meaning as R1,

G1 and G2 are the same or different and are phenylene or a monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue, which phenylene and monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue are optionally substituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of halogen, -CN , -N02, OH, Ci-30-alkyl, C2-30-alkenyl, C2-30-alkynyl, -Z17-O-Ci-30-alkyl, -Z17-S-Ci-3o-alkyl, -Z17-C3-io-cycloalkyl, -Z17-Cs-io-cycloalkenyl, -Z17-C8-io-cycloalkynyl, -Z17-C6-i4-aryl, -Z17-monovalent 3 to 12 membered aliphatic heterocyclic residue and -Z17-monovalent 5 to 14 membered aromatic heterocyclic residue, wherein Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, Ce-io-cycloalkynyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of halogen, -CN, -NO2, *=0, -OH, -NH2, -NH(Ci-2o-alkyl),

-N(Ci-2o-alkyl)2, -N(Ci-20-alkyl)-C6-i4-aryl, -N(C6-i4-aryl)2, -S(0)mH, -S(O)m-Ci-20-alkyl, -S(0)2OH, -S(O)m-OCi-20-alkyl, -S(0)m-OC6-i4-aryl, -CHO, -C(O)-Ci-20-alkyl,

-C(0)-C6-i4-aryl, -C(0)OH, -C(O)-OCi-20-alkyl, -C(0)-OC6-i4-aryl, -C(0)NH2,

-C(O)NH-Ci-20-alkyl, -C(O)N(Ci-20-alkyl)2, -C(0)NH-C6-i4-aryl,

-C(O)N(Ci-20-alkyl)-C6-i4-aryl, -C(0)N(C6-i4-aryl)2, -C(S)NH2, -C(S)NH-Ci-20-alkyl, -C(S)N(Ci-20-alkyl)2, -C(S)N(C6-i4-aryl)2, -C(S)N(Ci-20-alkyl)-C6-i4-aryl,

-C(S)NH-C6-i4-aryl, -S(0)mNH2, -S(O)mNH(Ci-20-alkyl), -S(O)mN(Ci-20-alkyl)2,

-S(0)mNH(C6-i4-aryl), -S(O)mN (Ci-20-alkyl)-C6-i4-aryl, -S(0)mN(C6-i4-aryl)2, SiH3, SiH(Ci-20-alkyl)2, SiH2(Ci-20-alkyl) and Si(Ci-20-alkyl)3, and wherein C3-io-cycloalkyl, Cs-io-cycloalkenyl, -Ce-io-cycloalkynyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents Rk, wherein each Rk is independently selected from the group consisting of Ci-20-alkyl, C2-2o-alkenyl, C2-2o-alkynyl, Ci-2o-alkoxy, -S-Ci-2o-alkyl, Ci-2o-haloalkyl, wherein

Z17 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and

m at each occurrence is independently 0, 1 or 2,

L is C6-24-arylene or a bivalent 5 to 18 membered aromatic heterocyclic residue, wherein C6-24-arylene and bivalent 5 to 18 membered aromatic heterocyclic residue are optionally substituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of halogen, -CN , -N02, *=0, OH , *=C(Ci-3o-alkyl)2, Ci-3o-alkyl, C2-30-alkenyl, C2-30-alkynyl, -Z18-O-Ci-30-alkyl, -Z18-S-Ci-30-alkyl,

-Z18-C3-io-cycloalkyl, -Z18-Cs-io-cycloalkenyl, -Z18-C8-io-cycloalkynyl, -Z18-C6-i4-aryl, -Z18-monovalent 3 to 12 membered aliphatic heterocyclic residue and -Z18-monovalent 5 to 14 membered aromatic heterocyclic residue, wherein Ci-30-alkyl, C2-3o-alkenyl, C2-3o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, Ce-io-cycloalkynyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally sub- stituted with 1 to 4 substituents Rm, wherein each Rm is independently selected from the group consisting of halogen, -CN , -N02, *=0, -OH , -N H2, -N H (Ci-2o-alkyl), -N (Ci-20-alkyl)2, -N (Ci-20-alkyl)-C6-i4-aryl, -N (C6-i4-aryl)2, -S(0)0H , -S(O)o-Ci-20-alkyl, -S(0)2OH , -S(O)o-OCi-20-alkyl, -S(0)0-OC6-i4-aryl, -CHO, -C(O)-Ci-20-alkyl, -C(0)-C6-i4-aryl, -C(0)OH, -C(0)-OCi-2o-alkyl, -C(0)-OC6-i4-aryl, -C(0)NH2, -C(0)NH-Ci-2o-alkyl, -C(O)N(Ci-20-alkyl)2, -C(0)NH-C6-i4-aryl,

-C(O)N(Ci-20-alkyl)-C6-i4-aryl, -C(0)N(C6-i4-aryl)2, -C(S)NH2, -C(S)NH-Ci-2o-alkyl, -C(S)N(Ci-2o-alkyl)2, -C(S)N(C6-i4-aryl)2, -C(S)N(Ci-20-alkyl)-C6-i4-aryl,

-C(S)NH-C6-i -aryl, -S(0)0NH2, -S(O)oNH(Ci-20-alkyl), -S(O)oN(Ci-20-alkyl)2,

-S(0)0NH(C6-i4-aryl), -S(O)oN(Ci-20-alkyl)-C6-i4-aryl, -S(0)0N(C6-i4-aryl)2, SiH3, SiH(Ci-2o-alkyl)2, SiH2(Ci-20-alkyl) and Si(Ci-20-alkyl)3, and wherein C3-io-cycloalkyl, Cs-io-cycloalkenyl, -Ce-io-cycloalkynyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents Rn, wherein each Rn is independently selected from the group consisting of Ci-2o-alkyl, C2-2o-alkenyl, C2-2o-alkynyl, Ci-2o-alkoxy, -S-Ci-2o-alkyl, Ci-2o-haloalkyl, wherein

Z18 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene,

Ci-6-haloalkylene or a covalent bond, and

o at each occurrence is independently 0, 1 or 2, or L is

wherein

R23 and R24 can be the same or different and are H , halogen, -CN , Ci-3o-alkyl, C2-3o-alkenyl, C2-2o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, Ce-io-cycloalkynyl, Ci-3o-haloalkyl, monovalent 3 to 12 membered aliphatic heterocyclic residue, -X7-R25, -X8-Ar13, -X8-Ar14-Ar13, -X8-Ar14-R26 or -X8-Ar14-Ar15-R26,

wherein

X7 at each occurrence is independently -0-, -[Z19-0]c-, -[0-Z19]c-0-, -S-, -[Z19-S , -[S-Z19]c-S-, -S(O), -C(O)-, -C(0)0-, -C(0)N R27-, C(0)S-, -O(CO)-, -S(CO)-, -N R27C(0)- or -N R27-,

wherein

Z19 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or Ci-6-haloalkylene,

c at each occurrence is independently an integer from 1 to 10 and R27 at each occurrence is independently H , Ci-2o-alkyl, or -Z20-C6-i4-aryl, wherein Z20 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

R25 at each occurrence is independently Ci-30-alkyl, C2-3o-alkenyl or Ci-3o-haloalkyl,

X8 at each occurrence is independently -Z21-0-Z22-, -Z21-S-Z22-, -S(O)-, -C(O)-, -C(0)0-, -(CO)NR28, -C(0)S-, -O(CO)-, -S(CO)-, -NR28C(0)-, -NR28-,

-Z21-SiR282-Z22-, Ci-3o-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a covalent bond,

wherein

Z21 and Z22 at each occurrence are independently Ci-6-alkylene, C2-6-alkenyl- ene, Ci-6-haloalkylene or a covalent bond, and

R28 at each occurrence is independently H, Ci-20-alkyl, or -Z23-C6-i4-aryl, wherein

Z23 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

Ar12 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 mem- bered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 sub- stituents R°, wherein each R° is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar14 and Ar15 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to

4 substituents RP, wherein each RP is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R26 at each occurrence is independently Ci-20-alkyl, C2-2o-alkenyl, Ci-20-haloalkyl, Ci-2o-alkoxy, -X9-Ar16, -X9-Ar17-Ar16, -X9-Ar17-R29, or -X9-Ar17-Ar18-R29,

wherein

X9 at each occurrence is independently -Z24-0-Z25-, -Z24-S-Z25, -S(O)-, -C(O)-, -C(0)0-, -(CO)NR30, -C(0)S-, -O(CO)-, -S(CO)-, -NR30C(O)-, -NR30-,

-Z24-SiR302-Z25-, Ci-3o-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a cova- lent bond,

wherein

Z24 and Z25 at each occurrence are independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and

R30 at each occurrence is independently H, Ci-20-alkyl or -Z26-C6-i4-aryl, wherein

Z26 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, Ar16 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 mem- bered aromatic heterocyclic residue, each optionally substituted with 1 to 5 sub- stituents R*, wherein each is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar17 and Ar18 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents Rr, wherein each Rr is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R29 at each occurrence is independently Ci-20-alkyl, C2-2o-alkenyl, Ci-20-haloalkyl or Ci-2o-alkoxy, q and s are the same or different and are 0, 1 , 2, 3, 4 or 5, r is 0, 1 or 2, and n is an integer from 1 to 10Ό00.

2. The compound, oligomer or polymer of formula (1 ) of claim 1 , wherein A1 and A2 are S. 3. The compound, oligomer or polymer of formula (1 ) of claim 1 or 2, wherein E is selected from the group consisting of 4. The compound, oligomer or polymer of formula (1 ) of claim 1 or 2, wherein E is

5. The compound, oligomer or polymer of formula (1 ) of claim 1 or 2, wherein E is

R3

N

/ \

6. The compound, oligomer or polymer of formula (1 ) of any of claims 1 to 4, wherein R1 and R2 are the same or different and are H, Ci-30-alkyl, Ci-30-haloalkyl, -X1-R6 or -X2-Ar1,

wherein

X1 at each occurrence is independently -[Z1-0]a-, -[Z1-S-]a-, or -[S-Z1]a-S-,

wherein

Z1 at each occurrence is independently Ci-6-alkylene or Ci-6-haloalkylene, a at each occurrence is independently an integer from 1 to 10 and

R6 at each occurrence is independently Ci-30-alkyl or Ci-30-haloalkyl,

X2 at each occurrence is independently -Z3-0-Z4-, -Z3-S-Z4-, Ci-30-alkylene or

Ci-3o-haloalkylene,

wherein

Z3 and Z4 at each occurrence are independently Ci-6-alkylene or Ci-6-halo- alkylene, and

Ar1 at each occurrence is independently C6-i4-aryl, optionally substituted with 1 to 5 substituents Ra, wherein each Ra is independently selected from the group consist- ing of halogen Ci-6-alkyl and Ci-6-alkoxy.

7. The compound, oligomer or polymer of formula (1 ) of any of claims 1 to 4, wherein R1 and R2 are the same or different and are Ci-30-alkyl, preferably Ci-20-alkyl, more preferably Ci-6-alkyl.

8. The compound, oligomer or polymer of formula (1 ) of any of claims 1 to 3 and 5, wherein R3 is -X5-Ar7, -X5-Ar8-Ar7, -X5-Ar8-R13 or -X5-Ar8-Ar9-R13,

wherein

X5 at each occurrence is a covalent bond,

Ar7 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents Re, wherein each Re is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar8 and Ar9 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents Rf, wherein each Rf is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R13 at each occurrence is independently Ci-20-alkyl, C2-2o-alkenyl, Ci-20-haloalkyl or Ci-2o-alkoxy.

9. The compound, oligomer or polymer of formula (1 ) of any of claims 1 to 3 and 5, wherein R3 is -X5-Ar8-R13,

wherein

X5 is a covalent bond,

Ar8 is C6-i4-arylene, preferably phenylene, and R13 is Ci-20-alkyl. 10. The compound, oligomer or polymer of formula (1 ) of any preceeding claims, wherein G1and G2 are the same or different and are phenylene, such as or, preferably, a monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue selected from the group consisting of which phenylene or monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue are optionally substituted with 1 to 2 substituents R, wherein each R is independently selected from the group consisting of Ci-30-alkyl, -Z17-0-Ci-3o-alkyl, -Z17-S-Ci-3o-alkyl, -Z17-C3-io-cycloalkyl, -Z17-C6-i4-aryl, -Z17-monovalent 3 to 12 membered aliphatic heterocyclic residue and -Z17-monovalent 5 to 14 membered aromatic heterocyclic resi- due, wherein Ci-30-alkyl, C3-io-cycloalkyl, C6-i4-aryl, monovalent s to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of halogen, -CN and *=0, and wherein C3-io-cycloalkyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents Rk, wherein each Rk is independently selected from the group consisting of Ci-20-alkyl, Ci-20-alkoxy, Ci-20-haloalkyl, wherein

Z17 at each occurrence is independently Ci-6-alkylene, Ci-6-haloalkylene or a covalent bond.

1 1 . The compound, oligomer or polymer of formula (1 ) of any preceeding claims, wherein G1 and G2 are the same or different and are a monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue which monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue is which monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue is substituted with 1 to 2 substituents R, wherein each R is independently selected from the group consisting of Ci-30-alkyl and -Z17-C6-i4-aryl, wherein Ci-30-alkyl and C6-i4-aryl are optionally substituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of halogen, -CN and *=0, and wherein C6-i4-aryl is optionally substituted with 1 to 4 substituents Rk, wherein each Rk is independently selected from the group consisting of Ci-20-alkyl and Ci-20-alkoxy, wherein

Z17 at each occurrence is a covalent bond.

12. The compound, oligomer or polymer of formula (1 ) of claims 1 , 10 and 1 1 , wherein each R is independently Ci-30-alkyl, preferably n-octyl, n-(2-ethyl)hexyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, n-undecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-penta- decyl, n-hexadecyl, n-heptadecyl, n-octadecyl, n-nonadecyl and n-icosyl (C20), more preferably, n-dodecyl.

13. The compound, oligomer or polymer of formula (1 ) of any preceeding claim, wherein

L is a bivalent 5 to 18 membered aromatic heterocyclic residue, wherein the bivalent 5 to 18 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of Ci-3o-alkyl, -Z18-O-Ci-30-alkyl, -Z18-S-Ci-30-alkyl, -Z18-C3-io-cycloalkyl, -Z18-C6-i4-aryl, -Z18-monovalent 3 to 12 membered aliphatic heterocyclic residue and -Z18-monovalent 5 to 14 membered aromatic heterocyclic residue, wherein Ci-30-alkyl, C3-io-cycloalkyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents Rm, wherein each Rm is independently selected from the group consisting of halogen, -CN and *=0, and wherein C3-io-cycloalkyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents Rn, wherein each Rn is independently selected from the group consisting of Ci-20-alkyl, Ci-20-alkoxy, Ci-20-haloalkyl, wherein

Z18 at each occurrence is independently Ci-6-alkylene, Ci-6-haloalkylene or a cova- lent bond, or

L is

wherein

R23 and R24 are the same or different and are H, halogen, -CN , Ci-30-alkyl, C2-3o-alkenyl, Ci-30-haloalkyl, -X7-R25, -X8-Ar13, -X8-Ar14-Ar13, -X8-Ar14-R26 or -X8-Ar14-Ar15-R26,

wherein

X7 at each occurrence is independently -0-, -[Z19-0]c-, -[0-Z19]c-0-, -S-, -[Z19-S-]c- or -[S-Z19]c-S-,

wherein

Z19 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or

Ci-6-haloalkylene,

c at each occurrence is independently an integer from 1 to 10 and

R25 at each occurrence is independently Ci-30-alkyl, C2-3o-alkenyl or Ci-30-haloalkyl,

X8 at each occurrence is independently -Z21-0-Z22-, -Z21-S-Z22-, Ci-30-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a covalent bond,

wherein

Z21 and Z22 at each occurrence are independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and Ar13 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 substituents R°, wherein each R° is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, Ar14 and Ar15 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents RP, wherein each RP is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R26 at each occurrence is independently Ci-20-alkyl, C2-2o-alkenyl, Ci-20-haloalkyl or Ci-2o-alkoxy.

14. The compound, oligomer or polymer of formula (1 ) of any of preceeding claim, wherein

L is is a bivalent 5 to 18 membered aromatic heterocyclic residue selected from the group consisting of

wherein the bivalent 5 to 18 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R, wherein each R has the same meaning as depicted in claim 13, and wherein R* is hydrogen or Ci-30-alkyl, or L is

wherein

R23 and R24 have the same meaning as depicted in claim 13.

15. The compound, oligomer or polymer of formula (1 ) of any preceeding claim, wherein

L is

wherein each R' has the meaning as depicted in claim or

L is

wherein

R23 and R24 are the same or different and have the meaning as depicted in claim 13.

16. The compound, oligomer or polymer of formula (1 ) of any of claims 1 , and 13 to 15, wherein

R is independently selected from the group consisting of Ci-3o-alkyl and -Z18-Ce-i4-aryl, wherein Ci-30-alkyl and C6-i4-aryl are optionally substituted with 1 to 4 substituents Rm, wherein each Rm is independently selected from the group consisting of halogen, -CN and *=0, and wherein C6-i4-aryl is optionally substituted with 1 to 4 substituents Rn, wherein each Rn is independently selected from the group consisting of Ci-20-alkyl and C1-20- alkoxy, wherein

Z18 at each occurrence is a covalent bond, and

R23 and R24 are the same or different and are H, Ci-30-alkyl, Ci-30-haloalkyl, -X7-R25 or -X8-Ar13,

wherein

X7 at each occurrence is independently -[Z19-0]c-, -[Z19-S-]c-, or -[S-Z19]c-S-,

wherein

Z19 at each occurrence is independently Ci-6-alkylene or Ci-6-haloalkylene, c at each occurrence is independently an integer from 1 to 10 and

R25 at each occurrence is independently Ci-30-alkyl or Ci-30-haloalkyl,

X8 at each occurrence is independently -Z21-0-Z22-, -Z21-S-Z22-, Ci-30-alkylene or Ci-3o-haloalkylene,

wherein

Z21 and Z22 at each occurrence are independently Ci-6-alkylene or

Ci-6-haloalkylene, and Ar13 at each occurrence is independently C6-i4-aryl, optionally substituted with 1 to 5 substituents R°, wherein each R° is independently selected from the group consisting of halogen Ci-6-alkyl and Ci-6-alkoxy.

17. The compound, oligomer or polymer of formula (1 ) of any of claims 1 , and 13 to 15, wherein each R is independently Ci-30-alkyl, preferably n-octyl, n-(2-ethyl)hexyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, n-undecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl, n-nonadecyl and n-icosyl (C20), more preferably, n-hexadecyl. and

R23 and R24 are the same or different and are H , Ci-30-alkyl or Ci-30-haloalkyl, preferably H.

18. The compound, oligomer or polymer of formula (1 ) of any preceeding claim, wherein q, r and s are 0 or 1 , with the proviso that q, r and s are not all 0 at the same time.

19. The compound, oligomer or polymer of formula (1 ) of any preceeding claim, wherein n is an integer from 1 to 5000, 1 to 1000, 1 to 100, 1 to 50 or from 1 to 30, preferably from 2 to 5000, 2 to 1000, 2 to 50 or from 2 to 30. 20. An electronic device comprising the compound, oligomer or polymer of formula (1 ) of any preceeding claim.

21 . The electronic device of claim 20, wherein the electronic device is an organic field effect transistor.

22. Use of the compound, oligomer or polymer of formula (1 ) of any of claims 1 to 19 as organic semiconducting material.

Description:
Semiconductor Materials prepared from Bridged Bithiazole Copolymers

Organic semiconducting materials can be used in electronic devices such as organic photovoltaic (OPV) cells, organic field-effect transistors (OFETs) and organic light emit- ting diodes (OLEDs).

It is desirable that the organic semiconducting materials are compatible with liquid processing techniques such as spin coating, solution casting or printing. Liquid processing techniques are convenient from the point of processability, and can also be ap- plied to plastic substrates. Thus, organic semiconducting materials which are compatible with liquid processing techniques allow the production of low cost, light weight and, optionally also flexible, electronic devices, which is a clear advantage of these organic semiconducting materials compared to inorganic semiconducting materials. Furthermore, it is desirable that the organic semiconducting materials are stable, in particular towards oxidation.

When used in organic field-effect transistors (OFETs), the organic semiconducting materials should show a high charge carrier mobility and a high on/off ratio.

The use of organic semiconducting materials in electronic devices, in particular in organic field effect transistors (OFETs) is known in the art.

Fuchigami, H.; Tsumura, A.; Koezuka, H. Appl. Phys. Lett. 1993, 63, 1372-1374 de- scribes the use of poly(2,5-thienylenevinylene) in field-effect transistors.

Bao, Z.; Dobadalapur, A.; Lovinger, A. J. Appl. Phys. Lett. 1996, 69, 4108-41 10 describes the use of regioregular poly(3-hexylthiophene) in field-effect transistors. Zhang, M.; Tsao, H. N.; Pisula, W.; Yang, C; Mishra, A. K.; Mullen, K.

J. Am. Chem. Soc. 2007, 129, 3472-3473 describes polymers of formula

for use in organic field effect transistors (OFETs).

Xiao, S; Zhou H.; You, W. Macromolecules 2008, 41, 5688-5696 describes the following polymers

as donor materials for use in photovoltaic devices.

Scharber, M. C; Koppe, M.; Gao, J.; Cordelia, F.; Loi, M. A.; Denk, P.; Morana, M .; Egelhaaf, H.-J.; Forberich, K.; Dennler, G.; Gaudiana, R.; Waller, D.; Zhu, Z.; Shi, X.; Brabec, C. J. Adv. Mater. 2009, 21, 1 -4 describes the following polymers

as donor materials for use in solar cells.

Rieger, R.; Beckmann, D.; Pisula, W.; Steffen, W.; Kastler, M.; Mullen K. Adv. Mater. 2010, 22, 83-86 describes the following polymers

for use in organic field-effect transistor (OFET).

Kim, D. H.; Lee, B.-L-; Moon, H.; Kang, H. M.; Jeong, E. J.; Park, J.; Han, K.-M.; Lee, S.; Yoo, B. W.; Koo, B. W.; Kim, J. Y.; Lee, W. H.; Cho, K.; Becerril, H. A.; Z. Bao Z. J. Am. Chem. Soc. 2009, 131, 6124-6132 describes the polymer

for use in organic field effect transistors (OFETs).

Osaka, I.; Sauve, G.; Zhang, R.; Kowalewski, T.; McCullough R. D. Adv. Mater. 2007, 19, 4160-4165 describes the polymers

for use in organic field effect transistors (OFETs). EP 2 085 401 A1 describes benzobisthiazole polymers comprising a unit having the following formula

wherein each of R 1 , R 2 , R 3 and R 4 represents a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted alkoxy group or a substituted or unsubstituted thioalkoxy group, wherein at least one of R 1 , R 2 , R 3 and R 4 is not a hydrogen atom, and n is a positive integer, wherein when n is 2 or more, each of R 3 is the same as or different from the others and each of R 4 is the same or different from the others, for use in transistors.

US 2008/0121281 A1 describes photovoltaic cells with thiazole-containing polymers such as bithiazole-containing polymers, cyclopentadithiazole-containing polymers or thiazolothiazole-containing polymers. Cyclopentadithiazole-containing polymers can be polymers which include a first comonomer repeat unit comprising a cyclopentadithia- zole moiety, and a second comonomer repeat unit different from the first comonomer repeat unit. In some embodiments, the first comonomer repeat unit includes a cyclopentadithiazole moiety of formula

in which each of R 1 and R 2 , independently, is H, Ci-20-alkyl, Ci-20-alkoxy, C3-20-CVCI0- alkyl, Ci-20-heterocycloalkyl, aryl, heteroaryl, halo, CN, OR, C(0)R, C(0)OR, or S0 2 R; R being H, Ci-20-alkyl, Ci-20-alkoxy, C3-2o-cycloalkyl, Ci-20-heterocycloalkyl, aryl, or heteroaryl.

WO 2009/069687 describes a polymer represented by the general formula

wherein Z 21 and Z 22 independently represent, for example, -S- It is the object of the present invention to provide organic semiconducting materials suitable for use in electronic devices, in particular in organic field effect transistors (OFETs), where the organic semiconducting materials show a high oxidative stability, particularly in ambient conditions, and are compatible with liquid processing techniques. The organic field effect transistors comprising the organic semiconducting materials should show an acceptable charge carrier mobility and current on/off ratio.

This object is solved by the compound, oligomer or polymer of claim 1 and the elec- tronic device of claim 19.

The compound, oligomer or polymer of the present invention are of formula

wherein

A 1 and A 2 can be the same or different and are S or Se, E is selected from the group consisting of

wherein

R 1 and R 2 can be the same or different and are H, halogen, -CN, Ci-30-alkyl, C2-3o-alkenyl, C2- 2 o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, Ce-io-cycloalkynyl,

Ci-3o-haloalkyl, monovalent 3 to 12 membered aliphatic heterocyclic residue, -X 1 -R 6 , -X 2 -Ar 1 , -X 2 -Ar 2 -Ar 1 , -X 2 -Ar 2 -R 7 or -X 2 -Ar 2 -Ar 3 -R 7 ,

wherein

X 1 at each occurrence is independently -0-, -[Z 1 -0] a -, -[0-Z 1 ] a -0-, -S-, -[Z 1 -S-] a -, -[S-ZVS-, -S(O), -C(O)-, -C(0)0-, -C(0)NR 8 -, C(0)S-, -O(CO)-, -S(CO)-,

-NR 8 C(0)- or -NR 8 -,

wherein

Z 1 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or Ci-6-haloalkylene,

a at each occurrence is independently an integer from 1 to 10 and

R 8 at each occurrence is independently H, Ci-20-alkyl, or -Z 2 -C6-i4-aryl, wherein

Z 2 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

R 6 at each occurrence is independently Ci-30-alkyl, C2-3o-alkenyl or Ci-30-haloalkyl,

X 2 at each occurrence is independently -Z 3 -0-Z 4 -, -Z 3 -S-Z 4 -, -S(O)-, -C(O)-, -C(0)0-, -(CO)NR 9 , -C(0)S-, -O(CO)-, -S(CO)-, -NR 9 C(0)-, -NR 9 -, -Z 3 -SiR 9 2 -Z 4 -, Ci-3o-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a covalent bond,

wherein

Z 3 and Z 4 at each occurrence are independently Ci-6-alkylene, C2-6-alkenyl- ene, Ci-6-haloalkylene or a covalent bond, and

R 9 at each occurrence is independently H , Ci-20-alkyl, or -Z 5 -C6-i4-aryl, wherein

Z 5 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

Ar 1 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 sub- stituents R a , wherein each R a is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 2 and Ar 3 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R b , wherein each R b is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R 7 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl, Ci-20-haloalkyl, Ci-2o-alkoxy, -X 3 -Ar 4 , -X 3 -Ar 5 -Ar 4 , -X 3 -Ar 5 -R 10 , or -X S -Ar S -Are-R 10 ,

wherein

X 3 at each occurrence is independently -Z 6 -0-Z 7 -, -Z 6 -S-Z 7 , -S(O)-, -C(O)-, -C(0)0-, -(CO)NR 11 , -C(0)S-, -O(CO)-, -S(CO)-, -NR 11 C(0)-, -NR 11 -,

-Z 6 -SiR 1 1 2-Z 7 -, Ci-3o-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a covalent bond,

wherein

Z 6 and Z 7 at each occurrence are independently Ci-6-alkylene,

C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and

R 11 at each occurrence is independently H , Ci-20-alkyl or -Z 8 -C6-i4-aryl, wherein

Z 8 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, Ar 4 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R c , wherein each R c is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 5 and Ar 6 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R d , wherein each R d is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R 10 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl, Ci-2o-haloalkyl or Ci-20-alkoxy, R 3 , R 4 and R 5 can be the same or different and are H, halogen, -CN, Ci-30-alkyl, C2-3o-alkenyl, C2- 2 o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, Ce-io-cycloalkynyl, Ci-3o-haloalkyl, monovalent 3 to 12 membered aliphatic heterocyclic residue, -X 4 -R 12 , -X 5 -Ar 7 , -X 5 -Ar 8 -Ar 7 , -X 5 -Ar 8 -R 13 or -X 5 -Ar 8 -Ar 9 -R 13 ,

wherein

X 4 at each occurrence is independently -[Z 9 -0] b -, -[Z 9 -S-] b -, -S(O)-, -C(O)-,

-C(0)0-, -C(0)NR 14 - or C(0)S-,

wherein

Z 9 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or Ci-6-haloalkylene,

b at each occurrence is independently an integer from 1 to 10 and

R 14 at each occurrence is independently H, Ci-20-alkyl, or -Z 10 -C6-i4-aryl, wherein

Z 10 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

R 12 at each occurrence is independently Ci-30-alkyl, C2-3o-alkenyl or Ci-3o-haloalkyl,

X 5 at each occurrence is independently -Z 11 -0-Z 12 , -Z 11 -S-Z 12 -, -S(O)-, -C(O)-, -C(0)0-, -(CO)NR 15 , -C(0)S-, -Z 11 -SiR 1 ¾-Z 12 -, Ci- 30 -alkylene, C 2 - 30 -alkenylene,

Ci-3o-haloalkylene or a covalent bond,

wherein

Z 11 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or Ci-6-haloalkylene,

Z 12 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene,

Ci-6-haloalkylene or a covalent bond, and

R 15 at each occurrence is independently H, Ci-20-alkyl, or -Z 13 -C6-i4-aryl, wherein Z 13 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

Ar 7 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 mem- bered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R e , wherein each R e is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 8 and Ar 9 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to

4 substituents R f , wherein each R f is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl and

R 13 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl, Ci-20-haloalkyl, Ci-2o-alkoxy, -X 6 -Ar 10 , -X 6 -Ar 11 -Ar 10 , -X 6 -Ar 11 -R 16 , or -X 6 -Ar 11 -Ar 12 -R 17 ,

wherein

X 6 at each occurrence is independently -Z 14 -0-Z 15 -, -Z 14 -S-Z 15 , -S(O)-, -C(O)-, -C(0)0-, -(CO)NR 18 , -C(0)S-, -O(CO)-, -S(CO)-, -NR 18 C(0)-, -NR 18 -,

-Z 14 -SiR 18 2-Z 15 -, Ci-3o-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a cova- lent bond,

wherein

Z 14 and Z 15 at each occurrence are independently Ci-6-alkylene,

C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and

R 18 at each occurrence is independently H, Ci-20-alkyl or -Z 16 -C 6 -i4-aryl, wherein

Z 16 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene,

Ci-6-haloalkylene or a covalent bond,

Ar 10 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to

5 substituents Rs, wherein each Ra is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 11 and Ar 12 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R h , wherein each R h is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl and

R 17 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl,

Ci-2o-haloalkyl or Ci-20-alkoxy, is O or C(CN) 2 , and R 20 and R 21 are the same or different and are R 22 or CN,

wherein R 22 has the same meaning as R 1 , G 1 and G 2 are the same or different and are phenylene or a monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue, which phenylene and monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue are optionally substituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of halogen, -CN, -N0 2 , -OH, Ci- 30 -alkyl, C 2 - 30 -alkenyl, C 2 - 30 -alkynyl, -Z 17 -O-Ci- 30 -alkyl, -Z 17 -S-Ci- 3 o-alkyl, -Z 17 -C 3 -io-cycloalkyl, -Z 17 -Cs-io-cycloalkenyl, -Z 17 -C8-io-cycloalkynyl, -Z 17 -C6-i4-aryl, -Z 17 -monovalent 3 to 12 membered aliphatic heterocyclic residue and -Z 17 -monovalent 5 to 14 membered aromatic heterocyclic residue, wherein Ci- 3 o-alkyl, C 2 - 3 o-alkenyl, C 2 - 3 o-alkynyl, C 3 -io-cycloalkyl, Cs-io-cycloalkenyl, Ce-io-cycloalkynyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of halogen, -CN, -NO2, *=0, -OH, -NH 2 , -NH(Ci-2o-alkyl),

-N(Ci-2o-alkyl) 2 , -N(Ci- 20 -alkyl)-C 6 -i4-aryl, -N(C 6 -i 4 -aryl) 2 , -S(0) m H, -S(O) m -Ci- 20 -alkyl, -S(0) 2 OH, -S(O)m-OCi- 20 -alkyl, -S(0) m -OC 6 -i4-aryl, -CHO, -C(O)-Ci- 20 -alkyl,

-C(0)-C 6 -i4-aryl, -C(0)OH, -C(O)-OCi- 20 -alkyl, -C(0)-OC 6 -i 4 -aryl, -C(0)NH 2 ,

-C(O)NH-Ci- 20 -alkyl, -C(O)N(Ci- 20 -alkyl) 2 , -C(0)NH-C 6 -i 4 -aryl,

-C(O)N(Ci- 20 -alkyl)-C 6 -i4-aryl, -C(0)N(C 6 -i 4 -aryl) 2 , -C(S)NH 2 , -C(S)NH-Ci- 20 -alkyl, -C(S)N(Ci- 20 -alkyl) 2 , -C(S)N(C 6 -i 4 -aryl) 2 , -C(S)N(Ci- 20 -alkyl)-C 6 -i4-aryl,

-C(S)NH-C 6 -i4-aryl, -S(0) m NH 2 , -S(O) m NH(Ci- 20 -alkyl), -S(O) m N(Ci- 20 -alkyl) 2 ,

-S(0)mNH(C 6 -i4-aryl), -S(O)mN(Ci- 20 -alkyl)-C 6 -i4-aryl, -S(0) m N(C 6 -i4-aryl) 2 , SiH 3 , SiH(Ci- 20 -alkyl) 2 , SiH 2 (Ci- 20 -alkyl) and Si(Ci- 20 -alkyl) 3 , and wherein C 3 -io-cycloalkyl, Cs-io-cycloalkenyl, -Ce-io-cycloalkynyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R k , wherein each R k is independently selected from the group consisting of Ci-20-alkyl, C 2 - 2 o-alkenyl, C 2 - 2 o-alkynyl, Ci- 2 o-alkoxy, -S-Ci- 2 o-alkyl, Ci- 2 o-haloalkyl, wherein

Z 17 at each occurrence is independently Ci-6-alkylene, C 2 -6-alkenylene,

Ci-6-haloalkylene or a covalent bond, and

m at each occurrence is independently 0, 1 or 2,

L is C6- 2 4-arylene or a bivalent 5 to 18 membered aromatic heterocyclic residue, wherein C6- 2 4-arylene and bivalent 5 to 18 membered aromatic heterocyclic residue are optionally substituted with 1 to 4 substituents R, wherein each R is independently se- lected from the group consisting of halogen, -CN, -NO2, *=0, OH, *=C(Ci-3o-alkyl) 2 , Ci-30-alkyl, C 2 - 30 -alkenyl, C 2 -3o-alkynyl, -Z 18 -O-Ci- 30 -alkyl, -Z 18 -S-Ci- 30 -alkyl,

-Z 18 -C 3 -io-cycloalkyl, -Z 18 -Cs-io-cycloalkenyl, -Z 18 -C8-io-cycloalkynyl, -Z 18 -C6-i4-aryl, -Z 18 -monovalent 3 to 12 membered aliphatic heterocyclic residue and -Z 18 -monovalent 5 to 14 membered aromatic heterocyclic residue, wherein Ci- 3 o-alkyl, C 2 - 3 o-alkenyl, C 2 - 3 o-alkynyl, C 3 -io-cycloalkyl, Cs-io-cycloalkenyl, Ce-io-cycloalkynyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally sub- stituted with 1 to 4 substituents R m , wherein each R m is independently selected from the group consisting of halogen, -CN, -NO2, *=0, -OH, -NH 2 , -NH(Ci-2o-alkyl),

-N(Ci-2o-alkyl) 2 , -N(Ci- 20 -alkyl)-C 6 -i4-aryl, -N(C 6 -i4-aryl) 2 , -S(0) 0 H, -S(O) o -Ci- 20 -alkyl, -S(0) 2 OH, -S(O)o-OCi- 20 -alkyl, -S(0) 0 -OC 6 -i 4 -aryl, -CHO, -C(O)-Ci- 20 -alkyl,

-C(0)-C 6 -i4-aryl, -C(0)OH, -C(O)-OCi- 20 -alkyl, -C(0)-OC 6 -i 4 -aryl, -C(0)NH 2 ,

-C(O)NH-Ci- 20 -alkyl, -C(O)N(Ci- 20 -alkyl) 2 , -C(0)NH-C 6 -i 4 -aryl,

-C(O)N(Ci- 20 -alkyl)-C 6 -i4-aryl, -C(0)N(C 6 -i 4 -aryl) 2 , -C(S)NH 2 , -C(S)NH-Ci- 20 -alkyl, -C(S)N(Ci- 20 -alkyl) 2 , -C(S)N(C 6 -i 4 -aryl) 2 , -C(S)N(Ci- 20 -alkyl)-C 6 -i4-aryl,

-C(S)NH-C 6 -i4-aryl, -S(0) 0 NH 2 , -S(O) o NH(Ci- 20 -alkyl), -S(O) o N(Ci- 20 -alkyl) 2 ,

-S(0) 0 NH(C 6 -i4-aryl), -S(O) o N(Ci- 20 -alkyl)-C 6 -i4-aryl, -S(0) 0 N(C 6 -i 4 -aryl) 2 , SiH 3 ,

SiH(Ci- 20 -alkyl) 2 , SiH 2 (Ci- 20 -alkyl) and Si(Ci- 20 -alkyl) 3 , and wherein C 3 -io-cycloalkyl, Cs-io-cycloalkenyl, -Ce-io-cycloalkynyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R n , wherein each R n is independently selected from the group consisting of Ci-20-alkyl, C 2 - 2 o-alkenyl, C 2 - 2 o-alkynyl, Ci- 2 o-alkoxy, -S-Ci- 2 o-alkyl, Ci- 2 o-haloalkyl, wherein

Z 18 at each occurrence is independently Ci-6-alkylene, C 2 -6-alkenylene,

Ci-6-haloalkylene or a covalent bond, and

o at each occurrence is independently 0, 1 or 2, or

wherein R 23 and R 24 can be the same or different and are H , halogen, -CN , Ci-30-alkyl, C2-3o-alkenyl, C2- 2 o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, Ce-io-cycloalkynyl, Ci-3o-haloalkyl, monovalent 3 to 12 membered aliphatic heterocyclic residue, -X 7 -R 25 , -X 8 -Ar 13 , -X 8 -Ar 14 -Ar 13 , -X 8 -Ar 14 -R 26 or -X 8 -Ar 14 -Ar 15 -R 26 ,

wherein

X 7 at each occurrence is independently -0-, -[Z 19 -0] c -, -[0-Z 19 ] c -0-, -S-, -[Z 19 -S-] c , -[S-Z 19 ]c-S-, -S(O), -C(O)-, -C(0)0-, -C(0)N R 27 -, C(0)S-, -O(CO)-, -S(CO)-, -N R 27 C(0)- or -N R 27 -,

wherein

Z 19 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or

Ci-6-haloalkylene,

c at each occurrence is independently an integer from 1 to 10 and R 27 at each occurrence is independently H , Ci-20-alkyl, or -Z 20 -C6-i4-aryl, wherein

Z 20 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene,

Ci-6-haloalkylene or a covalent bond,

R 25 at each occurrence is independently Ci-30-alkyl, C2-3o-alkenyl or Ci-3o-haloalkyl,

X 8 at each occurrence is independently -Z 21 -0-Z 22 -, -Z 21 -S-Z 22 -, -S(O)-, -C(O)-, -C(0)0-, -(CO)NR 28 , -C(0)S-, -O(CO)-, -S(CO)-, -NR 28 C(0)-, -NR 28 -,

-Z 21 -SiR 28 2-Z 22 -, Ci-3o-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a covalent bond,

wherein

Z 21 and Z 22 at each occurrence are independently Ci-6-alkylene, C2-6-alkenyl- ene, Ci-6-haloalkylene or a covalent bond, and

R 28 at each occurrence is independently H, Ci-20-alkyl, or -Z 23 -C6-i4-aryl, wherein

Z 23 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

Ar 13 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 sub- stituents R°, wherein each R° is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 14 and Ar 15 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents RP, wherein each RP is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and R 26 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl, Ci-20-haloalkyl, Ci-2o-alkoxy, -X 9 -Ar 16 , -X 9 -Ar 17 -Ar 16 , -X 9 -Ar 17 -R 29 , or -X 9 -Ar 17 -Ar 18 -R 29 ,

wherein

X 9 at each occurrence is independently -Z 24 -0-Z 25 -, -Z 24 -S-Z 25 , -S(O)-, -C(O)-, -C(0)0-, -(CO)NR 30 , -C(0)S-, -O(CO)-, -S(CO)-, -N R 30 C(O)-, -N R 30 -,

-Z 24 -SiR 30 2-Z 25 -, Ci-3o-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a cova- lent bond,

wherein

Z 24 and Z 25 at each occurrence are independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and

R 30 at each occurrence is independently H, Ci-2o-alkyl or -Z 26 -C 6 -i4-aryl, wherein

Z 26 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

Ar 16 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R*, wherein each R^ is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 17 and Ar 18 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R r , wherein each R r is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R 29 at each occurrence is independently Ci-2o-alkyl, C2-2o-alkenyl,

Ci-2o-haloalkyl or Ci-20-alkoxy, q and s are the same or different and are 0, 1 , 2, 3, 4 or 5, r is 0, 1 or 2, and n is an integer from 1 to 10Ό00.

Preferred are oligomers or polymers of formula

wherein

A 1 and A 2 can be the same or different and are S or Se, E is selected from the group consisting of

wherein

R 1 and R 2 can be the same or different and are H, halogen, -CN , Ci-30-alkyl, C2-3o-alkenyl, C2- 2 o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, Ce-io-cycloalkynyl, Ci-3o-haloalkyl, monovalent 3 to 12 membered aliphatic heterocyclic residue, -X 1 -R 6 , -X 2 -Ar 1 , -X 2 -Ar 2 -Ar 1 , -X 2 -Ar 2 -R 7 or -X 2 -Ar 2 -Ar 3 -R 7 ,

wherein

X 1 at each occurrence is independently -0-, -[Z 1 -0] a -, -[0-Z 1 ] a -0-, -S-, -[Z 1 -S-] a -, -[S-Z 1 ] a -S-, -S(O), -C(O)-, -C(0)0-, -C(0)NR 8 -, C(0)S-, -O(CO)-, -S(CO)-, -NR 8 C(0)- or -NR 8 -,

wherein

Z 1 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or Ci-6-haloalkylene,

a at each occurrence is independently an integer from 1 to 10 and

R 8 at each occurrence is independently H, Ci-20-alkyl, or -Z 2 -C6-i4-aryl, wherein

Z 2 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

R 6 at each occurrence is independently Ci-30-alkyl, C2-3o-alkenyl or Ci-30-haloalkyl,

X 2 at each occurrence is independently -Z 3 -0-Z 4 -, -Z 3 -S-Z 4 -, -S(O)-, -C(O)-, -C(0)0-, -(CO)NR 9 , -C(0)S-, -O(CO)-, -S(CO)-, -NR 9 C(0)-, -NR 9 -, -Z 3 -SiR 9 2 -Z 4 -, Ci-3o-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a covalent bond,

wherein

Z 3 and Z 4 at each occurrence are independently Ci-6-alkylene, C2-6-alkenyl- ene, Ci-6-haloalkylene or a covalent bond, and

R 9 at each occurrence is independently H, Ci-20-alkyl, or -Z 5 -C6-i4-aryl, wherein

Z 5 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, Ar 1 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 sub- stituents R a , wherein each R a is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 2 and Ar 3 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R b , wherein each R b is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R 7 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl, Ci-20-haloalkyl, Ci-2o-alkoxy, -X 3 -Ar 4 , -X 3 -Ar 5 -Ar 4 , -X 3 -Ar 5 -R 10 , or -X S -Ar S -Are-R 10 ,

wherein

X 3 at each occurrence is independently -Z 6 -0-Z 7 -, -Z 6 -S-Z 7 , -S(O)-, -C(O)-, -C(0)0-, -(CO)NR 11 , -C(0)S-, -O(CO)-, -S(CO)-, -NR 11 C(0)-, -NR 11 -,

-Z 6 -SiR 11 2-Z 7 -, Ci-3o-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a cova- lent bond,

wherein

Z 6 and Z 7 at each occurrence are independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and

R 11 at each occurrence is independently H , Ci-20-alkyl or -Z 8 -C6-i4-aryl, wherein

Z 8 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

Ar 4 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R c , wherein each R c is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 5 and Ar 6 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R d , wherein each R d is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R 10 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl,

Ci-2o-haloalkyl or Ci-20-alkoxy,

R 3 , R 4 and R 5 can be the same or different and are H, halogen, -CN, Ci-30-alkyl, C2-3o-alkenyl, C2- 2 o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, Ce-io-cycloalkynyl, Ci-3o-haloalkyl, monovalent 3 to 12 membered aliphatic heterocyclic residue, -X 4 -R 12 , -X 5 -Ar 7 , -X 5 -Ar 8 -Ar 7 , -X 5 -Ar 8 -R 13 or -X 5 -Ar 8 -Ar 9 -R 13 , wherein

X 4 at each occurrence is independently -[Z 9 -0] b -, -[Z 9 -S-] b -, -S(O)-, -C(O)-, -C(0)0-, -C(0)N R 14 - or C(0)S-,

wherein

Z 9 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or Ci-6-haloalkylene,

b at each occurrence is independently an integer from 1 to 10 and

R 14 at each occurrence is independently H , Ci-2o-alkyl, or -Z 10 -C6-i4-aryl, wherein

Z 10 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

R 12 at each occurrence is independently Ci-3o-alkyl, C2- 3 o-alkenyl or

Ci-3o-haloalkyl,

X 5 at each occurrence is independently -Z 11 -0-Z 12 , -Z 11 -S-Z 12 -, -S(O)-, -C(O)-, -C(0)0-, -(CO)NR 15 , -C(0)S-, -Z 11 -SiR 15 2-Z 12 -, Ci- 30 -alkylene, C 2 - 30 -alkenylene, Ci-3o-haloalkylene or a covalent bond,

wherein

Z 11 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or

Ci-6-haloalkylene,

Z 12 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and

R 15 at each occurrence is independently H, Ci-20-alkyl, or -Z 13 -C6-i4-aryl, wherein

Z 13 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

Ar 7 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 mem- bered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R e , wherein each R e is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 8 and Ar 9 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to

4 substituents R f , wherein each R f is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl and

R 13 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl, Ci-20-haloalkyl, Ci-2o-alkoxy, -X 6 -Ar 10 , -X 6 -Ar 11 -Ar 10 , -X 6 -Ar 11 -R 16 , or -X 6 -Ar 11 -Ar 12 -R 17 ,

wherein

X 6 at each occurrence is independently -Z 14 -0-Z 15 -, -Z 14 -S-Z 15 , -S(O)-, -C(O)-, -C(0)0-, -(CO)NR 18 , -C(0)S-, -O(CO)-, -S(CO)-, -NR 18 C(0)-, -NR 18 -, -Z 14 -SiR 18 2-Z 15 -, Ci-3o-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a cova- lent bond,

wherein

Z 14 and Z 15 at each occurrence are independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and

R 18 at each occurrence is independently H, Ci-20-alkyl or -Z 16 -C 6 -i4-aryl, wherein

Z 16 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

Ar 10 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents Rs, wherein each Ra is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 11 and Ar 12 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R h , wherein each R h is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl and

R 17 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl,

Ci-2o-haloalkyl or Ci-20-alkoxy, R 19 is O or C(CN) 2 , and

R 20 and R 21 are the same or different and are R 22 or CN,

wherein R 22 has the same meaning as R 1 , G 1 and G 2 are the same or different and are phenylene or a monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue, which phenylene and monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue are optionally substituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of halogen, -CN, -N0 2 , -OH, Ci- 30 -alkyl, C 2 - 30 -alkenyl, C 2 - 30 -alkynyl, -Z 17 -O-Ci- 30 -alkyl, -Z 17 -S-Ci- 3 o-alkyl, -Z 17 -C 3 -io-cycloalkyl, -Z 17 -Cs-io-cycloalkenyl, -Z 17 -C8-io-cycloalkynyl, -Z 17 -C6-i4-aryl, -Z 17 -monovalent 3 to 12 membered aliphatic heterocyclic residue and -Z 17 -monovalent 5 to 14 membered aromatic heterocyclic residue, wherein Ci- 3 o-alkyl, C2- 3 o-alkenyl, C2- 3 o-alkynyl, C 3 -io-cycloalkyl, Cs-io-cycloalkenyl, Ce-io-cycloalkynyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of halogen, -CN, -NO2, *=0, -OH, -NH 2 , -NH(Ci-2o-alkyl), -N(Ci-2o-alkyl) 2 , -N(Ci- 20 -alkyl)-C 6 -i4-aryl, -N(C 6 -i4-aryl) 2 , -S(0) m H, -S(O) m -Ci- 20 -alkyl, -S(0) 2 OH, -S(O)m-OCi- 20 -alkyl, -S(0) m -OC 6 -i4-aryl, -CHO, -C(O)-Ci- 20 -alkyl, -C(0)-C 6 -i4-aryl, -C(0)OH , -C(O)-OCi- 20 -alkyl, -C(0)-OC 6 -i 4 -aryl, -C(0)N H 2 ,

-C(O)NH-Ci- 20 -alkyl, -C(O)N(Ci- 20 -alkyl) 2 , -C(0)NH-C 6 -i 4 -aryl,

-C(O)N(Ci- 20 -alkyl)-C 6 -i4-aryl, -C(0)N(C 6 -i 4 -aryl) 2 , -C(S)N H 2 , -C(S)NH-Ci- 20 -alkyl, -C(S)N(Ci- 20 -alkyl) 2 , -C(S)N(C 6 -i 4 -aryl) 2 , -C(S)N(Ci- 20 -alkyl)-C 6 -i4-aryl,

-C(S)NH-C 6 -i4-aryl, -S(0) m NH 2 , -S(O) m NH(Ci- 20 -alkyl), -S(O) m N(Ci- 20 -alkyl) 2 ,

-S(0)mN H (C 6 -i4-aryl), -S(O)mN (Ci- 20 -alkyl)-C 6 -i4-aryl, -S(0) m N(C 6 -i4-aryl) 2 , SiH 3 , SiH(Ci-2o-alkyl) 2 , SiH 2 (Ci- 20 -alkyl) and Si(Ci- 20 -alkyl) 3 , and wherein C 3 -io-cycloalkyl, Cs-io-cycloalkenyl, -Ce-io-cycloalkynyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R k , wherein each R k is independently selected from the group consisting of Ci- 2 o-alkyl, C 2 - 2 o-alkenyl, C 2 - 2 o-alkynyl, Ci- 2 o-alkoxy, -S-Ci- 2 o-alkyl, Ci- 2 o-haloalkyl, wherein

Z 17 at each occurrence is independently Ci-6-alkylene, C 2 -6-alkenylene, Ci-6-haloalkylene or a covalent bond, and

m at each occurrence is independently 0, 1 or 2,

L is C6- 2 4-arylene or a bivalent 5 to 18 membered aromatic heterocyclic residue, wherein C6- 2 4-arylene and bivalent 5 to 18 membered aromatic heterocyclic residue are optionally substituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of halogen, -CN , -N0 2 , *=0, OH, *=C(Ci- 3 o-alkyl) 2 , Ci- 30 -alkyl, C 2 - 30 -alkenyl, C 2 - 30 -alkynyl, -Z 18 -O-Ci- 30 -alkyl, -Z 18 -S-Ci- 30 -alkyl,

-Z 18 -C 3 -io-cycloalkyl, -Z 18 -Cs-io-cycloalkenyl, -Z 18 -C8-io-cycloalkynyl, -Z 18 -C6-i4-aryl, -Z 18 -monovalent 3 to 12 membered aliphatic heterocyclic residue and -Z 18 -monovalent 5 to 14 membered aromatic heterocyclic residue, wherein Ci- 3 o-alkyl, C 2 - 3 o-alkenyl, C 2 - 3 o-alkynyl, C 3 -io-cycloalkyl, Cs-io-cycloalkenyl, Ce-io-cycloalkynyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally sub- stituted with 1 to 4 substituents R m , wherein each R m is independently selected from the group consisting of halogen, -CN , -N0 2 , *=0, -OH , -N H 2 , -N H (Ci- 2 o-alkyl), -N (Ci- 20 -alkyl) 2 , -N (Ci- 20 -alkyl)-C 6 -i4-aryl, -N (C 6 -i 4 -aryl) 2 , -S(0) 0 H , -S(O) o -Ci- 20 -alkyl, -S(0) 2 OH , -S(O)o-OCi- 20 -alkyl, -S(0) 0 -OC 6 -i 4 -aryl, -CHO, -C(O)-Ci- 20 -alkyl, -C(0)-C 6 -i4-aryl, -C(0)OH , -C(O)-OCi- 20 -alkyl, -C(0)-OC 6 -i 4 -aryl, -C(0)N H 2 ,

-C(O)N H-Ci- 20 -alkyl, -C(O)N (Ci- 20 -alkyl) 2 , -C(0)N H-C 6 -i 4 -aryl,

-C(O)N (Ci- 20 -alkyl)-C 6 -i4-aryl, -C(0)N (C 6 -i 4 -aryl) 2 , -C(S)N H 2 , -C(S)N H-Ci- 20 -alkyl, -C(S)N (Ci- 20 -alkyl) 2 , -C(S)N (C 6 -i 4 -aryl) 2 , -C(S)N (Ci- 20 -alkyl)-C 6 -i4-aryl,

-C(S)N H-C 6 -i4-aryl, -S(0) 0 N H 2 , -S(O) o N H (Ci- 20 -alkyl), -S(O) o N (Ci- 20 -alkyl) 2 , -S(0) 0 NH(C 6 -i4-aryl), -S(0) 0 N(Ci-2o-alkyl)-C 6 -i4-aryl, -S(0) 0 N(C 6 -i4-aryl) 2 , SiH 3 ,

SiH(Ci-2o-alkyl) 2 , SiH 2 (Ci- 20 -alkyl) and Si(Ci- 20 -alkyl) 3 , and wherein C 3 -io-cycloalkyl, Cs-io-cycloalkenyl, -Ce-io-cycloalkynyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R n , wherein each R n is independently selected from the group consisting of Ci- 2 o-alkyl, C 2 - 2 o-alkenyl, C 2 - 2 o-alkynyl, Ci- 2 o-alkoxy, -S-Ci- 2 o-alkyl, Ci- 2 o-haloalkyl, wherein

Z 18 at each occurrence is independently Ci-6-alkylene, C 2 -6-alkenylene,

Ci-6-haloalkylene or a covalent bond, and

o at each occurrence is independently 0, 1 or 2, or

L is

wherein

R 23 and R 24 can be the same or different and are H, halogen, -CN , Ci- 3 o-alkyl, C 2 - 3 o-alkenyl, C 2 - 2 o-alkynyl, C 3 -io-cycloalkyl, Cs-io-cycloalkenyl, Ce-io-cycloalkynyl, Ci- 3 o-haloalkyl, monovalent 3 to 12 membered aliphatic heterocyclic residue, -X 7 -R 25 , -X 8 -Ar 13 , -X 8 -Ar 14 -Ar 13 , -X 8 -Ar 14 -R 26 or -X 8 -Ar 14 -Ar 15 -R 26 ,

wherein

X 7 at each occurrence is independently -0-, -[Z 19 -0] c -, -[0-Z 19 ] c -0-, -S-, -[Z 19 -S-] c - , -[S-Z 19 ]c-S-, -S(O), -C(O)-, -C(0)0-, -C(0)N R 27 -, C(0)S-, -O(CO)-, -S(CO)-, -N R 27 C(0)- or -N R 27 -,

wherein

Z 19 at each occurrence is independently Ci-6-alkylene, C 2 -6-alkenylene or Ci-6-haloalkylene,

c at each occurrence is independently an integer from 1 to 10 and R 27 at each occurrence is independently H, Ci- 2 o-alkyl, or -Z 20 -C6-i4-aryl, wherein

Z 20 at each occurrence is independently Ci-6-alkylene, C 2 -6-alkenylene,

Ci-6-haloalkylene or a covalent bond, R 25 at each occurrence is independently Ci-30-alkyl, C2-3o-alkenyl or

Ci-3o-haloalkyl,

X 8 at each occurrence is independently -Z 21 -0-Z 22 -, -Z 21 -S-Z 22 -, -S(O)-, -C(O)-, -C(0)0-, -(CO)NR 28 , -C(0)S-, -O(CO)-, -S(CO)-, -NR 28 C(0)-, -NR 28 -,

-Z 21 -SiR 28 2-Z 22 -, Ci-3o-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a covalent bond,

wherein

Z 21 and Z 22 at each occurrence are independently Ci-6-alkylene, C2-6-alkenyl- ene, Ci-6-haloalkylene or a covalent bond, and

R 28 at each occurrence is independently H, Ci-2o-alkyl, or -Z 23 -C6-i4-aryl, wherein

Z 23 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

Ar 13 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 sub- stituents R°, wherein each R° is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 14 and Ar 15 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents RP, wherein each RP is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R 26 at each occurrence is independently Ci-2o-alkyl, C2-2o-alkenyl, Ci-2o-haloalkyl, Ci-2o-alkoxy, -X 9 -Ar 16 , -X 9 -Ar 17 -Ar 16 , -X 9 -Ar 17 -R 29 , or -X 9 -Ar 17 -Ar 18 -R 29 ,

wherein

X 9 at each occurrence is independently -Z 24 -0-Z 25 -, -Z 24 -S-Z 25 , -S(O)-, -C(O)-, -C(0)0-, -(CO)NR 30 , -C(0)S-, -O(CO)-, -S(CO)-, -NR 30 C(O)-, -NR 30 -,

-Z 24 -SiR 30 2-Z 25 -, Ci-3o-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a covalent bond,

wherein

Z 24 and Z 25 at each occurrence are independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and

R 30 at each occurrence is independently H, Ci-2o-alkyl or -Z 26 -C 6 -i4-aryl, wherein

Z 26 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

Ar 16 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R*, wherein each is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 17 and Ar 18 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R r , wherein each R r is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R 29 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl,

Ci-2o-haloalkyl or Ci-20-alkoxy, q and s are the same or different and are 0, 1 , 2, 3, 4 or 5, r is 0, 1 or 2, and n is an integer from 2 to 10Ό00.

Examples of halogen are -F, -CI, -Br and -I.

Examples of Ci-6-alkyl are methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, ferf-butyl, n-pentyl, neopentyl, isopentyl and n-hexyl. Examples of Ci-20-alkyl are Ci-6-alkyl, n-heptyl, n-octyl, n-(2-ethyl)hexyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, n-undecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl, n-nonadecyl and n-icosyl (C20). Examples of Ci-30-alkyl are Ci-20-alkyl, n-docosyl (C22), n-tetracosyl (C24), n-hexacosyl (C26), n-octacosyl (C28) and n-triacontyl

Examples of Ci- 6 -haloalkyl are CF 3 , CH F 2 , CH 2 F, C 2 F 5 , CH 2 (CH 2 )4CF 3 , CF 3 , CCI 3 , CHC , CH2CI, C2CI5 and CH 2 (CH 2 )4CCI 3 . Examples of Ci-20-haloalkyl and of

Ci- 30 -haloalkyl are Ci- 6 -haloalkyl and CH 2 (CH 2 ) 8 CF 3 , CH 2 (CH 2 )i4CF 3 . Examples of Ci-6-alkoxy are methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, sec-butoxy, isobutoxy, ferf-butoxy, n-pentoxy, neopentoxy, isopentoxy and n-hexoxy. Examples of Ci-20-alkoxy are Ci-6-alkoxy, n-heptoxy, n-octoxy, n-nonoxy and n-decoxy, n-undecoxy, n-dodoxy, n-undecoxy, n-dodecoxy, n-tridecoxy, n-tetradecoxy, n-pentadecoxy, n-hexadecoxy, n-heptadecoxy, n-octadecoxy, n-nonadecoxy and n-eicosoxy (C20).

Examples of C2-2o-alkenyl are ethenyl, propenyl, c/s-2-butenyl, frans-2-butenyl, 3-butenyl, c/s-2-pentenyl, frans-2-pentenyl, c/s-3-pentenyl, frans-3-pentenyl, 4-pentenyl, 2-methyl-3-butenyl, hexenyl, heptenyl, octenyl, nonenyl, docenyl, undo- cenyl and oleyl (Cie). Examples of C2-2o-alkenyl are also butadienyl, pentadienyl, hexadienyl, linoleyl (Cie), linolenyl (Cie) and arachidonyl (C20). Examples of C2-3o-alkenyl are C2-2o-alkenyl and erucyl (C22).

Examples of C2-2o-alkynyl are ethynyl, 2-propynyl, 2-butynyl, 3-butynyl, pentynyl, hexynyl, heptynyl, octynyl, nonynyl, decynyl, undecynyl, dodecynyl, undecynyl, dode- cynyl, tridecynyl, tetradecynyl, pentadecynyl, hexadecynyl, heptadecynyl, octadecynyl, nonadecynyl and icosynyl (C20). Examples of C2-3o-alkynyl are C2-2o-alkynyl.

Examples of C3-io-cycloalkyl are preferably monocyclic C3-io-cycloalkyls such as cyclo- propyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl, but include also polycyclic C3-io-cycloalkyls such as decalinyl, norbornyl and adamantyl. Examples of Cs-io-cycloalkenyl are preferably monocyclic Cs-io-cycloalkenyls such as cyclopentenyl, cyclohexenyl, cyclohexadienyl and cycloheptatrienyl, but include also polycyclic Cs-io-cycloalkenyls.

An example of Ce-io-cycloalkynyl is cyclooctynyl.

The monovalent 3 to 12 membered aliphatic heterocyclic residues can be monocyclic monovalent 3 to 8 membered aliphatic heterocyclic residues or polycyclic, for example bicyclic, monovalent 7 to 12 membered aliphatic heterocyclic residues.

Examples of monocyclic monovalent 3 to 8 membered aliphatic heterocyclic residues are monocyclic monovalent 5 membered aliphatic heterocyclic residues containing one heteroatom such as pyrrolidinyl, 1 -pyrrolinyl, 2-pyrrolinyl, 3-pyrrolinyl, tetrahydrofuryl, 2,3-dihydrofuryl, tetrahydrothiophenyl and 2,3-dihydrothiophenyl, monocyclic monova- lent 5 membered aliphatic heterocyclic residues containing two heteroatoms such as imidazolidinyl, imidazolinyl, pyrazolidinyl, pyrazolinyl, oxazolidinyl, oxazolinyl, isoxa- zolidinyl, isoxazolinyl, thiazolidinyl, thiazolinyl, isothiazolidinyl and isothiazolinyl, monocyclic monovalent 5 membered aliphatic heterocyclic residues containing three heteroatoms such as 1 ,2,3-triazolyl, 1 ,2,4-triazolyl and 1 ,4,2-dithiazolyl, monocyclic mono- valent 6 membered aliphatic heterocyclic residues containing one heteroatom such as piperidyl, piperidino, tetrahydropyranyl, pyranyl, thianyl and thiopyranyl, monocyclic monovalent 6 membered aliphatic heterocyclic residues containing two heteroatoms such as piperazinyl, morpholinyl and morpholino and thiazinyl, monocyclic monovalent 7 membered aliphatic heterocyclic residues containing one hereoatom such as aze- panyl, azepinyl, oxepanyl, thiepanyl, thiapanyl, thiepinyl, and monocyclic monovalent 7 membered aliphatic heterocyclic residues containing two hereoatom such as

1 ,2-diazepinyl and 1 ,3-thiazepinyl. The monovalent 3 to 12 membered aliphatic heterocyclic residues can contain one or more heteroatoms, which can independently be selected from the group consisting of nitrogen, oxygen, sulfur, phosphor, silicon and arsenic, preferably from the group consisting of nitrogen, oxygen and sulfur.

Examples of monocyclic monovalent 3 to 12 membered aliphatic heterocyclic residue substituted with *=0 are 2-oxazolidonyl, 4-piperidonyl, 4-piperidono, pyrimidine- 2,4(1 H,3H)-dionyl and 2-pyridonyl. An example of a bicyclic monovalent 7 to 12 membered aliphatic heterocyclic residue is decahydronaphthyl.

C6-i4-aryl can be monocyclic or polycyclic. Examples of C6-i4-aryl are monocyclic

C6-aryl such as phenyl, bicyclic Cg-io-aryl such as 1 -naphthyl, 2-naphthyl, indenyl, in- danyl and tetrahydronaphthyl, and tricyclic Ci2-i4-aryl such as anthryl, phenanthryl, fluo- renyl and s-indacenyl.

C6-i4-haloaryl can be monocyclic or polycyclic. Examples of C6-i4-haloaryl are 6-chloro- phenyl and 2-chlorophenyl.

The monovalent 5 to 14 membered aromatic heterocyclic residues can be monocyclic monovalent 5 to 8 membered aromatic heterocyclic residues, or polycyclic monovalent 7 to 12 membered aromatic heterocyclic residues, for example bicyclic or tricyclic monovalent 9 to 14 membered aromatic heterocyclic residues.

Examples of monocyclic monovalent 5 to 8 membered aromatic heterocyclic residues are monocyclic monovalent 5 membered aromatic heterocyclic residues containing one heteroatom such as pyrrolyl, furyl and thiophenyl, monocyclic monovalent 5 membered aromatic heterocyclic residues containing two heteroatoms such as imidazolyl, pyra- zolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, monocyclic monovalent 5 membered aromatic heterocyclic residues containing three heteroatoms such as 1 ,2,3-triazolyl, 1 ,2,4-triazolyl and oxadiazolyl, monocyclic monovalent s membered aromatic hetero- cyclic residues containing four heteroatoms such as tetrazolyl, monocyclic monovalent 6 membered aromatic heterocyclic residues containing one heteroatom such as pyridyl, monocyclic monovalent 6 membered aromatic heterocyclic residues containing two heteroatoms such as pyrazinyl, pyrimidinyl and pyridazinyl, monocyclic monovalent 6 membered aromatic heterocyclic residues containing three heteroatoms such as 1 ,2,3-triazinyl, 1 ,2,4-triazinyl and 1 ,3,5-triazinyl, monocyclic monovalent 7 membered aromatic heterocyclic residues containing one heteroatom such as azepinyl, and monocyclic monovalent 7 membered aromatic heterocyclic residues containing two heteroatoms such as 1 ,2-diazepinyl, Examples of bicyclic monovalent 7 to 12 membered aromatic heterocyclic residues are bicyclic 9 membered aromatic heterocyclic residues containing one heteroatom such as indolyl, isoindolyl, indolizinyl, indolinyl, benzofuryl, isobenzofuryl, benzothiophenyl and isobenzothiophenyl, bicyclic monovalent 9 membered aromatic heterocyclic residues containing two heteroatoms such as indazolyl, benzimidazolyl, benzimidazolinyl, benzoxazolyl, benzisooxazolyl, benzthiazolyl, benzisothiazolyl, furopyridyl and thieno- pyridyl, bicyclic monovalent 9 membered aromatic heterocyclic residues containing three heteroatoms such as benzotriazolyl, benzoxadiazolyl, oxazolopyridyl, isooxa- zolopyridyl, thiazolopyridyl, isothiazolopyridyl and imidazopyridyl, bicyclic monovalent 9 membered aromatic heterocyclic residues containing four heteroatoms such as purinyl, bicyclic monovalent 10 membered aromatic heterocyclic residues containing one heteroatom such as quinolyl, isoquinolyl, chromenyl and chromanyl, bicyclic monovalent 10 membered aromatic heterocyclic residues containing two heteroatoms such as quinoxalinyl, quinazolinyl, cinnolinyl, phthalazinyl, 1 ,5-naphthyridinyl and 1 ,8-naphthyridinyl, bicyclic monovalent 10 membered aromatic heterocyclic residues containing three heteroatoms such as pyridopyrazinyl, pyridopyrimidinyl and pyri- dopyridazinyl, and bicyclic monovalent 10 membered aromatic heterocyclic residues containing four heteroatoms such as pteridinyl.

Examples of tricyclic monovalent 9 to 14 membered aromatic heterocyclic residues are dibenzofuryl, acridinyl, phenoxazinyl, 7H-cyclopenta[1 ,2-b:3,4-b']dithiophenyl and 4H-cyclopenta[2,1 -b:3,4-b']dithiophenyl. The monovalent 5 to 14 membered aromatic heterocyclic residue can contain one or more heteroatoms which can independently be selected from the group consisting of nitrogen, oxygen, sulfur, phosphor, silicon and arsenic, preferably from the group consisting of nitrogen, oxygen and sulfur.

Examples of Ci-6-alkylene are methylene, ethylene, butylene, pentylene, hexylene and 2-methylpentylene. Examples of Ci-30-alkylene are Ci-6-alkylene, CH2(CH 2 )ioCH2 and Examples of C2-6-alkenylene are ethenylene, c/s-2-butenylene, frans-butenylene, c/s-2-pentenylene, frans-2-pentenylene, frans-2-hexenylene, frans-3-hexenylene and 2-methyl-frans-3-pentenylene. Examples of C2-3o-alkenylene are C2-6-alkenylene, CH2(CH 2 )4-CH=CH-(CH 2 )4CH2 and CH2(CH 2 )9-CH=CH-(CH 2 )9CH2. Examples of Ci- 6 -haloalkylene are CF 2 , CCI 2 , CF 2 CF 2 , CCI2CCI2, CHFCH 2 ,

CHFCH2CH2CHF and CHF(CH 2 )4CHF. Examples of Ci-30-haloalkylene are

Ci-6-haloalkylene, CHF(CH 2 )i 0 CHF and CHF(CH 2 ) 20 CHF. Examples of C6-i4-arylene are monocyclic C6-arylene such as phenylene, bicyclic

Cg-io-arylene such as 1 -naphthylene, 2-naphthyl, indenylene, indanylene and tetrahy- dronaphthylene, and tricyclic Ci2-i4-arylene such as anthrylene, phenanthrylene, fluo- renylene and s-indacenylene. Examples of C6-24-arylene are C6-i4-arylene and pyrenylene, tetracenylene, perylenylene, indenofluorenylene, pentacenylene, coronenylene and tetraphenylenylene.

The bivalent 5 to 14 membered aromatic heterocyclic residues can be monocyclic bivalent 5 to 8 membered aromatic heterocyclic residues, or polycyclic bivalent 7 to 12 membered aromatic heterocyclic residues, for example bicyclic or tricyclic bivalent 9 to 14 membered aromatic heterocyclic residues.

Examples of monocyclic bivalent 5 to 8 membered aromatic heterocyclic residues are monocyclic bivalent 5 membered aromatic heterocyclic residues containing one het- eroatom such as pyrrolylene, furylene and thiophenylene, monocyclic bivalent

5 membered aromatic heterocyclic residues containing two heteroatoms such as imi- dazolylene, pyrazolylene, oxazolylene, isoxazolylene, thiazolylene, isothiazolylene, monocyclic bivalent 5 membered aromatic heterocyclic residues containing three heteroatoms such as 1 ,2,3-triazolylene, 1 ,2,4-triazolylene and oxadiazolylene, monocyclic bivalent 5 membered aromatic heterocyclic residues containing four heteroatoms such as tetrazolylene, monocyclic bivalent 6 membered aromatic heterocyclic residues containing one heteroatom such as pyridylene, monocyclic bivalent 6 membered aromatic heterocyclic residues containing two heteroatoms such as pyrazinylene, pyrimidinylene and pyridazinylene, monocyclic bivalent 6 membered aromatic heterocyclic residues containing three heteroatoms such as 1 ,2,3-triazinylene, 1 ,2,4-triazinylene and

1 ,3,5-triazinylene, monocyclic bivalent 7 membered aromatic heterocyclic residues containing one heteroatom such as azepinylene, and monocyclic bivalent 7 membered aromatic heterocyclic residues containing two heteroatoms such as 1 ,2-diazepinylene. Examples of bicyclic bivalent 7 to 12 membered aromatic heterocyclic residues are bicyclic bivalent 9 membered aromatic heterocyclic residues containing one heteroatom such as indolylene, isoindolylene, indolizinylene, indolinylene, benzofurylene, is- obenzofurylene, benzothiophenylene and isobenzothiophenylene, bicyclic bivalent 9 membered aromatic heterocyclic residues containing two heteroatoms such as inda- zolylene, benzimidazolylene, benzimidazolinylene, benzoxazolylene, benzisooxa- zolylene, benzthiazolylene, benzisothiazolylene, furopyridylene and thienopyridylene, bicyclic bivalent 9 membered aromatic heterocyclic residues containing three heteroatoms such as benzotriazolylene, benzoxadiazolylene, oxazolopyridylene, isooxa- zolopyridylene, thiazolopyridylene, isothiazolopyridylene and imidazopyridylene, bi- cyclic bivalent 9 membered aromatic heterocyclic residues containing four heteroatoms such as purinylene, bicyclic bivalent 10 membered aromatic heterocyclic residues containing one heteroatom such as quinolylene, isoquinolylene, chromenylene and chromanylene, bicyclic bivalent 10 membered aromatic heterocyclic residues contain- ing two heteroatoms such as quinoxalinylene, quinazolinylene, cinnolinylene, phthalaz- inylene, 1 ,5-naphthyridinylene and 1 ,8-naphthyridinylene, bicyclic bivalent

10 membered aromatic heterocyclic residues containing three heteroatoms such as pyridopyrazinylene, pyridopyrimidinylene and pyridopyridazinylene, and bicyclic biva- lent 10 membered aromatic heterocyclic residues containing four heteroatoms such as pteridinylene.

Examples of tricyclic bivalent 9 to 14 membered aromatic heterocyclic residues containing one heteroatom are dibenzofurylene and acridinylene. Examples of a tricyclic bivalent 9 to 14 membered aromatic heterocyclic residues containing two heteroatoms are phenoxazinylene, 7H-cyclopenta[1 ,2-b:3,4-b']dithiophenylene and

4H-cyclopenta[2,1 -b:3,4-b']dithiophenylene.

Examples of bivalent 5 to 18 membered aromatic heterocyclic residues are bivalent 5 to 14 membered aromatic heterocyclic residues.

The bivalent 5 to 14 membered, repectively, 5 to 18 membered aromatic heterocyclic residue can contain one or more heteroatoms which can independently be selected from the group consisting of nitrogen, oxygen, sulfur, phosphor, silicon and arsenic, preferably from the group consisting of nitrogen, silicon and sulfur.

Preferably, A 1 and A 2 are S.

Preferably, E is selected from the group consisting of

More preferably, E is selected from the group consisting of

Most preferably, E is

R 1 v R 2 Preferably, R 1 and R 2 are the same or different and are H, halogen, -CN, Ci-30-alkyl, C 2 - 30 -alkenyl, Ci -3 o-haloalkyl, -X 1 -R 6 , -X 2 -Ar 1 , -X 2 -Ar 2 -Ar 1 , -X 2 -Ar 2 -R 7 or -X 2 -Ar 2 -Ar 3 -R 7 , wherein

X 1 at each occurrence is independently -0-, -[Z 1 -0] a -, -[0-Z 1 ] a -0-, -S-, -[Z 1 -S-] a -, -[S-Z 1 ] a -S-, -S(O), -C(O)-, -C(0)0-, -C(0)NR 8 -, C(0)S-, -O(CO)-, -S(CO)-,

-NR 8 C(0)- or -NR 8 -,

wherein

Z 1 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or

Ci-6-haloalkylene,

a at each occurrence is independently an integer from 1 to 10 and

R 8 at each occurrence is independently H, Ci-20-alkyl, or -Z 2 -C6-i4-aryl,

wherein

Z 2 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

R 6 at each occurrence is independently Ci-30-alkyl, C2-3o-alkenyl or Ci-30-haloalkyl,

X 2 at each occurrence is independently -Z 3 -0-Z 4 -, -Z 3 -S-Z 4 -, -S(O)-, -C(O)-, -C(0)0-, -(CO)NR 9 , -C(0)S-, -O(CO)-, -S(CO)-, -NR 9 C(0)-, -NR 9 -, -Z 3 -SiR 9 2 -Z 4 -,

Ci-3o-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a covalent bond,

wherein

Z 3 and Z 4 at each occurrence are independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and

R 9 at each occurrence is independently H, Ci-20-alkyl, or -Z 5 -C6-i4-aryl,

wherein

Z 5 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

Ar 1 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 substituents R a , wherein each R a is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 2 and Ar 3 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R b , wherein each R b is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R 7 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl, Ci-20-haloalkyl and Ci-2o-alkoxy. More preferably, R 1 and R 2 are the same or different and are H, halogen, -CN , Ci-30-alkyl, C 2 - 30 -alkenyl, Ci- 30 -haloalkyl, -X 1 -R 6 , -X 2 -Ar 1 , -X 2 -Ar 2 -Ar 1 , -X 2 -Ar 2 -R 7 or -X 2 -Ar 2 -Ar 3 -R 7 ,

wherein

X 1 at each occurrence is independently -0-, -[Z 1 -0] a -, -[0-Z 1 ] a -0-, -S-, -[Z 1 -S-] a -, or wherein

Z 1 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or Ci-6-haloalkylene,

a at each occurrence is independently an integer from 1 to 10 and

R 6 at each occurrence is independently Ci- 3 o-alkyl, C2- 3 o-alkenyl or Ci- 3 o-haloalkyl,

X 2 at each occurrence is independently -Z 3 -0-Z 4 -, -Z 3 -S-Z 4 -, Ci- 3 o-alkylene, C2-3o-alkenylene, Ci- 3 o-haloalkylene or a covalent bond,

wherein

Z 3 and Z 4 at each occurrence are independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and Ar 1 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 substituents R a , wherein each R a is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, Ar 2 and Ar 3 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R b , wherein each R b is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and R 7 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl, Ci-20-haloalkyl or Ci-2o-alkoxy.

Even more preferably, R 1 and R 2 are the same or different and are H, Ci- 3 o-alkyl, Ci-ao-haloalkyl, -X 1 -R 6 or -X 2 -Ar 1 ,

wherein

X 1 at each occurrence is independently -[Z 1 -0] a -, -[Z 1 -S-] a -, or -[S-Z 1 ] a -S-,

wherein

Z 1 at each occurrence is independently Ci-6-alkylene or Ci-6-haloalkylene, a at each occurrence is independently an integer from 1 to 10 and

R 6 at each occurrence is independently Ci- 3 o-alkyl or Ci- 3 o-haloalkyl, X 2 at each occurrence is independently -Z 3 -0-Z 4 -, -Z 3 -S-Z 4 -, Ci-30-alkylene or Ci-3o-haloalkylene,

wherein

Z 3 and Z 4 at each occurrence are independently Ci-6-alkylene or

Ci-6-haloalkylene, and

Ar 1 at each occurrence is independently C6-i4-aryl, optionally substituted with 1 to 5 substituents R a , wherein each R a is independently selected from the group consisting of halogen Ci-6-alkyl and Ci-6-alkoxy.

Most preferably, R 1 and R 2 are the same or different and are Ci-30-alkyl, Ci-30-haloalkyl or -X 2 -Ar 1 ,

wherein

X 2 at each occurrence is independently Ci-30-alkylene or Ci-30-haloalkylene, and

Ar 1 at each occurrence is independently C6-i4-aryl, optionally substituted with 1 to 5 substituents R a , wherein each R a is independently selected from the group consisting of halogen Ci-6-alkyl and Ci-6-alkoxy.

In particular, R 1 and R 2 are the same or different and are Ci-30-alkyl, for example Ci-2o-alkyl or Ci-6-alkyl, for example methyl or n-hexyl.

Preferably, R 3 is H, halogen, CN, Ci- 30 -alkyl, C 2 -3o-alkenyl, Ci- 30 -haloalkyl, -X 4 -R 12 , -X 5 -Ar 7 , -X 5 -Ar 8 -Ar 7 , -X 5 -Ar 8 -R 13 or -X 5 -Ar 8 -Ar 9 -R 13 ,

wherein

X 4 at each occurrence is independently -[Z 9 -0] b -, -[Z 9 -S-] b -, -S(O)-, -C(O)-, -C(0)0-, -C(0)NR 1 - or C(0)S-,

wherein

Z 9 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or Ci-6-haloalkylene,

b at each occurrence is independently an integer from 1 to 10 and

R 14 at each occurrence is independently H, Ci-20-alkyl, or -Z 10 -C6-i4-aryl,

wherein

Z 10 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

R 12 at each occurrence is independently Ci-30-alkyl, C2-3o-alkenyl or Ci-30-haloalkyl, X 5 at each occurrence is independently -Z 11 -0-Z 12 , -Z 11 -S-Z 12 -, -S(O)-, -C(O)-, -C(0)0-, -(CO)NR 15 , -C(0)S-, -Z 11 -SiR 15 2-Z 12 -, Ci- 30 -alkylene, C 2 - 30 -alkenylene, Ci- 3 o-haloalkylene or a covalent bond,

wherein

Z 11 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or

Ci-6-haloalkylene,

Z 12 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and

R 15 at each occurrence is independently H, Ci-20-alkyl, or -Z 13 -C6-i4-aryl,

wherein

Z 13 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

Ar 7 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents

R e , wherein each R e is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 8 and Ar 9 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R f , wherein each R f is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl and

R 13 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl, Ci-20-haloalkyl or Ci-2o-alkoxy.

More preferably, R 3 is H, Ci- 30 -alkyl, C 2 - 30 -alkenyl, Ci- 30 -haloalkyl, -X 4 -R 12 , -X 5 -Ar 7 , -X 5 -Ar 8 -Ar 7 , -X 5 -Ar 8 -R 13 or -X 5 -Ar 8 -Ar 9 -R 13 ,

wherein

X 4 at each occurrence is independently -[Z 9 -0]b- or -[Z 9 -S-]b-,

wherein

Z 9 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or Ci-6-haloalkylene, and

b at each occurrence is independently an integer from 1 to 10 and

R 12 at each occurrence is independently Ci- 3 o-alkyl, C2- 3 o-alkenyl or Ci- 3 o-haloalkyl,

X 5 at each occurrence is independently -Z 11 -0-Z 12 , -Z 11 -S-Z 12 -, Ci- 3 o-alkylene, C2- 3 o-alkenylene, Ci- 3 o-haloalkylene or a covalent bond,

wherein

Z 11 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or Ci-6-haloalkylene, and Z 12 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and

Ar 7 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents

R e , wherein each R e is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 8 and Ar 9 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R f , wherein each R f is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R 13 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl, Ci-20-haloalkyl or Ci-2o-alkoxy.

Most preferably, R 3 is -X 5 -Ar 7 , -X 5 -Ar 8 -Ar 7 , -X 5 -Ar 8 -R 13 or -X 5 -Ar 8 -Ar 9 -R 13 ,

wherein

X 5 at each occurrence is a covalent bond,

Ar 7 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R e , wherein each R e is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 8 and Ar 9 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R f , wherein each R f is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R 13 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl, Ci-20-haloalkyl or Ci-2o-alkoxy. In particular, R 3 is -X 5 -Ar 8 -R 13 ,

wherein

X 5 is a covalent bond,

Ar 8 is C6-i4-arylene, for example phenylene, and

R 13 is Ci-20-alkyl. For example R 3 is

Preferably, G 1 and G 2 are the same or different and are phenylene, such as or, preferably, a monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue selected from the group consisting of wherein

M 1 is S, O, NH or SiR s R s , preferably M 1 is S or NH, more preferably M 1 is S, wherein R s is hydrogen or Ci-30-alkyl, which phenylene or monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue are optionally substituted with 1 to 2 substituents R, wherein each R is independently selected from the group consisting of -CN , Ci-30-alkyl, -Z 17 -0-Ci-3o-alkyl,

-Z 17 -S-Ci- 30 -alkyl, -Z 17 -C 3 -io-cycloalkyl, -Z 17 -C 6 -i 4 -aryl, -Z 17 -monovalent 3 to 12 membered aliphatic heterocyclic residue and -Z 17 -monovalent 5 to 14 membered aromatic heterocyclic residue, wherein Ci-30-alkyl, C3-io-cycloalkyl, C6-i 4 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of halogen, -CN , *=0, -N H (Ci-2o-alkyl),

-N (Ci-2o-alkyl) 2 , -N (Ci- 20 -alkyl)-C 6 -i 4 -aryl, -N (C 6 -i 4 -aryl) 2 , -S(O) m -Ci- 20 -alkyl,

-S(O)m-OCi- 20 -alkyl, -S(0) m -OC 6 -i 4 -aryl, -CHO, -C(O)-Ci- 20 -alkyl, -C(0)-C 6 -i 4 -aryl, -C(O)-OCi- 20 -alkyl, -C(0)-OC 6 -i 4 -aryl, -C(0)N H 2 , -C(O)N H-Ci- 20 -alkyl,

-C(O)N (Ci- 20 -alkyl) 2 , -C(0)N H-C 6 -i 4 -aryl, -C(O)N (Ci- 20 -alkyl)-C 6 -i 4 -aryl,

-C(0)N (C 6 -i 4 -aryl) 2 , -C(S)N H 2 , -C(S)N H-Ci- 20 -alkyl, -C(S)N (Ci- 20 -alkyl) 2 ,

-C(S)N (C 6 -i -aryl) 2 , -C(S)N (Ci- 20 -alkyl)-C 6 -i -aryl, -C(S)N H-C 6 -i -aryl, -S(0) m N H 2 , -S(O) m N H (Ci- 20 -alkyl), -S(O) m N (Ci- 20 -alkyl) 2 , -S(0) m N H (C 6 -i -aryl),

-S(O)mN (Ci- 20 -alkyl)-C 6 -i 4 -aryl, -S(0) m N (C 6 -i 4 -aryl) 2 and Si(Ci- 20 -alkyl) 3 , and wherein C3-io-cycloalkyl, C6-i 4 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R k , wherein each R k is independently selected from the group consisting of Ci-20-alkyl, Ci-20-alkoxy, -S-Ci-20-alkyl, Ci-20-haloalkyl, wherein

Z 17 at each occurrence is independently Ci-6-alkylene, Ci-6-haloalkylene or a cova- lent bond, and

m at each occurrence is independently 0, 1 or 2.

Preferably, each R' is independently selected from the group consisting of Ci-30-alkyl, -Z 17 -0-Ci-3o-alkyl, -Z 17 -S-Ci- 30 -alkyl, -Z 17 -C 3 -i 0 -cycloalkyl, -Z 17 -C 6 -i 4 -aryl, -Z 17 -monovalent 3 to 12 membered aliphatic heterocyclic residue and -Z 17 -monovalent 5 to 14 mem- bered aromatic heterocyclic residue, wherein Ci- 3 o-alkyl, C 3 -io-cycloalkyl, C6-i 4 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of halogen, -CN and *=0, and wherein C 3 -io-cycloalkyl, C6-i 4 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R k , wherein each R k is independently selected from the group consisting of Ci-20-alkyl, Ci-20-alkoxy, Ci-20-haloalkyl, wherein

Z 17 at each occurrence is independently Ci-6-alkylene, Ci-6-haloalkylene or a cova- lent bond.

More preferably, each R is independently selected from the group consisting of Ci-3o-alkyl and -Z 17 -C6-i 4 -aryl, wherein Ci- 3 o-alkyl and C6-i 4 -aryl are optionally substituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of halogen, -CN and *=0, wherein

Z 17 at each occurrence is a covalent bond and

C6-i 4 -aryl is optionally substituted with 1 to 4 substituents R k , wherein each R k is independently selected from the group consisting of Ci-20-alkyl and Ci-20-alkoxy. Most preferably, each R' is independently Ci-30-alkyl, preferably n-octyl, n-(2-ethyl)- hexyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, n-undecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl, n-nonadecyl and n-icosyl (C20), more preferably, n-dodecyl.

More preferably, G 1 and G 2 are the same or different and are phenylene, such as or, preferably, a monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue selected from the group consisting of which phenylene or monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue are optionally substituted with 1 to 2 substituents R, wherein each R is independently selected from the group consisting of Ci-30-alkyl, -Z 17 -0-Ci-3o-alkyl, -Z 17 -S-Ci-3o-alkyl, -Z 17 -C3-io-cycloalkyl, -Z 17 -C6-i4-aryl, -Z 17 -monovalent 3 to 12 membered aliphatic het- erocyclic residue and -Z 17 -monovalent 5 to 14 membered aromatic heterocyclic residue, wherein Ci-30-alkyl, C3-io-cycloalkyl, C6-i4-aryl, monovalent s to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of halogen, -CN and *=0, and wherein C3-io-cycloalkyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R k , wherein each R k is independently selected from the group consisting of Ci-20-alkyl, Ci-20-alkoxy, Ci-20-haloalkyl, wherein

Z 17 at each occurrence is independently Ci-6-alkylene, Ci-6-haloalkylene or a cova- lent bond.

Most preferably, G 1 and G 2 are the same or different and are a monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue which monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue is which monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue is substituted with 1 to 2 substituents R, wherein each R' is independently selected from the group consisting of Ci-30-alkyl and -Z 17 -C6-i4-aryl, wherein Ci-30-alkyl and C6-i4-aryl are optionally substituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of halogen, -CN and *=0, and wherein C6-i4-aryl is optionally substituted with 1 to 4 substituents R k , wherein each R k is independently selected from the group consisting of Ci-20-alkyl and Ci-20-alkoxy, wherein

Z 17 at each occurrence is a covalent bond.

In particular, G 1 and G 2 are the same or different and are a monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue which monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue is which monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue is substi- tuted with 1 substituent R, wherein R is Ci-30-alkyl, preferably n-octyl, n-(2-ethyl)hexyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, n-undecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl, n-nonadecyl and n-icosyl (C20), more preferably, n-dodecyl.

Preferably, L is C6-24-arylene or a bivalent 5 to 18 membered aromatic heterocyclic residue, wherein C6-24-arylene and bivalent 5 to 18 membered aromatic heterocyclic residue are optionally substituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of -CN , Ci-30-alkyl, -Z 18 -0-Ci-3o-alkyl, -Z 18 -S-Ci- 30 -alkyl, -Z 18 -C 3 -io-cycloalkyl, -Z 18 -C 6 -i 4 -aryl, -Z 18 -monovalent 3 to 12 membered aliphatic heterocyclic residue and -Z 18 -monovalent 5 to 14 membered aromatic heterocyclic residue, wherein Ci-30-alkyl, C 3 -io-cycloalkyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R m , wherein each R m is independently selected from the group consisting of halogen, -CN , *=0, -N H (Ci-2o-alkyl), -N (Ci-2o-alkyl) 2 , -N (Ci- 20 -alkyl)-C 6 -i4-aryl, -N (C 6 -i4-aryl) 2 , -S(O) o -Ci- 20 -alkyl,

-S(O)o-OCi- 20 -alkyl, -S(0) 0 -OC 6 -i 4 -aryl, -CHO, -C(O)-Ci- 20 -alkyl, -C(0)-C 6 -i 4 -aryl, -C(O)-OCi- 20 -alkyl, -C(0)-OC 6 -i 4 -aryl, -C(0)N H 2 , -C(O)N H-Ci- 20 -alkyl,

-C(O)N (Ci- 20 -alkyl) 2 , -C(0)N H-C 6 -i 4 -aryl, -C(O)N (Ci- 20 -alkyl)-C 6 -i 4 -aryl,

-C(0)N (C 6 -i 4 -aryl) 2 , -C(S)N H 2 , -C(S)N H-Ci- 20 -alkyl, -C(S)N (Ci- 20 -alkyl) 2 ,

-C(S)N (C 6 -i -aryl) 2 , -C(S)N (Ci- 20 -alkyl)-C 6 -i -aryl, -C(S)N H-C 6 -i -aryl, -S(0) 0 NH 2 , -S(O)oN H (Ci- 20 -alkyl), -S(O) o N (Ci- 20 -alkyl) 2 , -S(0) 0 N H (C 6 -i -aryl),

-S(O) o N (Ci- 20 -alkyl)-C 6 -i 4 -aryl, -S(0) 0 N (C 6 -i 4 -aryl) 2 and Si(Ci- 20 -alkyl) 3 , and wherein C 3 -io-cycloalkyl, C6-i 4 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R k , wherein each R k is independently selected from the group consisting of Ci- 2 o-alkyl, Ci- 2 o-alkoxy, -S-Ci- 2 o-alkyl, Ci- 2 o-haloalkyl, wherein

Z 18 at each occurrence is independently Ci-6-alkylene, Ci-6-haloalkylene or a cova- lent bond, and

o at each occurrence is independently 0, 1 or 2, or

L is

wherein

R 23 and R 24 are the same or different and are H , halogen, -CN , Ci- 3 o-alkyl,

C 2 - 30 -alkenyl, Ci- 30 -haloalkyl, -X 7 -R 25 , -X 8 -Ar 13 , -X 8 -Ar 14 -Ar 13 , -X 8 -Ar 14 -R 26 or

-X 8 -Ar 14 -Ar 15 -R 26 ,

wherein

X 7 at each occurrence is independently -0-, -[Z 19 -0] 0 -, -[0-Z 19 ] 0 -0-, -S-,

-[Z 19 -S-] 0 -, -[S-Z 19 ] 0 -S-, -S(O), -C(O)-, -C(0)0-, -C(0)N R 27 -, C(0)S-, -O(CO)-, -S(CO)-, -N R 27 C(0)- or -N R 27 -,

wherein

Z 19 at each occurrence is independently Ci-6-alkylene, C 2 -6-alkenylene or Ci-6-haloalkylene,

c at each occurrence is independently an integer from 1 to 10 and

R 27 at each occurrence is independently H , Ci- 2 o-alkyl, or -Z 20 -C6-i 4 -aryl, wherein Z 20 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

R 25 at each occurrence is independently Ci-30-alkyl, C2-3o-alkenyl or Ci-3o-haloalkyl,

X 8 at each occurrence is independently -Z 21 -0-Z 22 -, -Z 21 -S-Z 22 -, -S(O)-, -C(O)-, -C(0)0-, -(CO)NR 28 , -C(0)S-, -O(CO)-, -S(CO)-, -NR 28 C(0)-, -NR 28 -,

-Z 21 -SiR 28 2-Z 22 -, Ci-3o-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a covalent bond,

wherein

Z 21 and Z 22 at each occurrence are independently Ci-6-alkylene, C2-6-alkenyl- ene, Ci-6-haloalkylene or a covalent bond, and

R 28 at each occurrence is independently H, Ci-20-alkyl, or -Z 23 -C6-i 4 -aryl, wherein

Z 23 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

Ar 14 at each occurrence is independently C6-i 4 -aryl or monovalent 5 to 14 mem- bered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 sub- stituents R°, wherein each R° is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 14 and Ar 15 at each occurrence are independently C6-i 4 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to

4 substituents RP, wherein each RP is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R 26 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl, Ci-20-haloalkyl and Ci-2o-alkoxy.

Preferably, each R is independently selected from the group consisting of Ci-30-alkyl, -Z 18 -O-Ci- 30 -alkyl, -Z 18 -S-Ci- 30 -alkyl, -Z 18 -C 3 -io-cycloalkyl, -Z 18 -C 6 -i 4 -aryl, -Z 18 -monovalent 3 to 12 membered aliphatic heterocyclic residue and -Z 18 -monovalent 5 to 14 membered aromatic heterocyclic residue, wherein Ci-30-alkyl, C3-io-cycloalkyl, C6-i 4 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R m , wherein each R m is independently selected from the group consisting of halogen, -CN and *=0, and wherein C3-io-cycloalkyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R n , wherein each R n is independently selected from the group consisting of Ci-20-alkyl, Ci-20-alkoxy, Ci-20-haloalkyl, wherein

Z 18 at each occurrence is independently Ci-6-alkylene, Ci-6-haloalkylene or a cova- lent bond.

More preferably, each R is independently selected from the group consisting of Ci-3o-alkyl and -Z 18 -C6-i4-aryl, wherein Ci-30-alkyl and C6-i4-aryl are optionally substituted with 1 to 4 substituents R m , wherein each R m is independently selected from the group consisting of halogen, -CN and *=0, and wherein C6-i4-aryl is optionally substituted with 1 to 4 substituents R n , wherein each R n is independently selected from the group consisting of Ci-20-alkyl and Ci-20-alkoxy, wherein

Z 18 at each occurrence is a covalent bond.

Most preferably, each R is independently Ci-30-alkyl, preferably n-octyl, n-(2-ethyl)- hexyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, n-undecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl, n-nonadecyl and n-icosyl (C20), more preferably, n-hexadecyl.

Preferably, R 23 and R 24 are the same or different and are H, halogen, -CN , Ci-30-alkyl, C 2 - 30 -alkenyl, Ci- 30 -haloalkyl, -X 7 -R 25 , -X 8 -Ar 13 , -X 8 -Ar 14 -Ar 13 , -X 8 -Ar 14 -R 26 or

-X 8 -Ar 14 -Ar 15 -R 26 ,

wherein

X 7 at each occurrence is independently -0-, -[Z 19 -0] c -, -[0-Z 19 ] c -0-, -S-, -[Z 19 -S-] c -, or -[S-Z 19 ] c -S-,

wherein

Z 19 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or Ci-6-haloalkylene,

c at each occurrence is independently an integer from 1 to 10 and

R 25 at each occurrence is independently Ci-30-alkyl, C2-3o-alkenyl or Ci-30-haloalkyl, X 8 at each occurrence is independently -Z 21 -0-Z 22 -, -Z 21 -S-Z 22 -, Ci-30-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a covalent bond,

wherein

Z 21 and Z 22 at each occurrence are independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and

Ar 13 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 substituents R°, wherein each R° is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 14 and Ar 15 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents RP, wherein each RP is independently selected from the group consist- ing of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R 26 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl, Ci-20-haloalkyl or Ci-2o-alkoxy. More preferably, R 23 and R 24 are the same or different and are H , Ci-30-alkyl, Ci-30-halo- alkyl, -X 7 -R 25 or -X 8 -Ar 13 ,

wherein

X 7 at each occurrence is independently -[Z 19 -0] c -, -[Z 19 -S-] c -, or -[S-Z 19 ] c -S-,

wherein

Z 19 at each occurrence is independently Ci-6-alkylene or Ci-6-haloalkylene, c at each occurrence is independently an integer from 1 to 10 and

R 25 at each occurrence is independently Ci-30-alkyl or Ci-30-haloalkyl, X 8 at each occurrence is independently -Z 21 -0-Z 22 -, -Z 21 -S-Z 22 -, Ci-30-alkylene or Ci-3o-haloalkylene,

wherein

Z 21 and Z 22 at each occurrence are independently Ci-6-alkylene or

Ci-6-haloalkylene, and

Ar 13 at each occurrence is independently C6-i4-aryl, optionally substituted with 1 to 5 substituents R°, wherein each R° is independently selected from the group consisting of halogen Ci-6-alkyl and Ci-6-alkoxy.

Most preferably, R 23 and R 24 are the same or different and are H, Ci-30-alkyl or

Ci-3o-haloalkyl, in particular H. More preferably, L is a bivalent 5 to 18 membered aromatic heterocyclic residue, wherein the bivalent 5 to 18 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R', wherein each R is independently selected from the group consisting of Ci-30-alkyl, -Z 18 -0-Ci-3o-alkyl, -Z 18 -S-Ci-3o-alkyl, -Z 18 -C3-io-cycloalkyl, -Z 18 -C6-i4-aryl, -Z 18 -monovalent 3 to 12 membered aliphatic heterocyclic residue and -Z 18 -monovalent 5 to 14 membered aromatic heterocyclic residue, wherein Ci-30-alkyl, C3-io-cycloalkyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R m , wherein each R m is independently selected from the group consisting of halogen, -CN and *=0, and wherein C3-io-cycloalkyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R n , wherein each R n is independently selected from the group consisting of Ci-20-alkyl, Ci-20-alkoxy, Ci-20-haloalkyl, wherein

Z 18 at each occurrence is independently Ci-6-alkylene, Ci-6-haloalkylene or a cova- lent bond, or

wherein

R 23 and R 24 are the same or different and are H, halogen, -CN , Ci-30-alkyl, C2-3o-alkenyl, Ci-3o-haloalkyl, -X 7 -R 25 , -X 8 -Ar 13 , -X 8 -Ar 14 -Ar 13 , -X 8 -Ar 14 -R 26 or -X 8 -Ar 14 -Ar 15 -R 26 ,

wherein

X 7 at each occurrence is independently -0-, -[Z 19 -0] c -, -[0-Z 19 ] c -0-, -S-, -[Z 19 -S-] c -, or -[S-Z 19 ] c -S-,

wherein

Z 19 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or Ci-6-haloalkylene,

c at each occurrence is independently an integer from 1 to 10 and R 25 at each occurrence is independently Ci-30-alkyl, C2-3o-alkenyl or Ci-30-haloalkyl,

X 8 at each occurrence is independently -Z 21 -0-Z 22 -, -Z 21 -S-Z 22 -, Ci-30-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a covalent bond,

wherein

Z 21 and Z 22 at each occurrence are independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and

Ar 13 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 substituents R°, wherein each R° is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 14 and Ar 15 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents RP, wherein each RP is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R 26 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl, Ci-20-haloalkyl or Ci-2o-alkoxy.

wherein the bivalent 5 to 18 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R, wherein each R R is independently selected from the group consisting of Ci-30-alkyl and -Z 18 -C6-i4-aryl, wherein Ci-30-alkyl and C6-i4-aryl are optionally substituted with 1 to 4 substituents R m , wherein each R m is independently selected from the group consisting of halogen, -CN and *=0, and wherein C6-i4-aryl is optionally substituted with 1 to 4 substituents R n , wherein each R n is independently selected from the group consisting of Ci-20-alkyl and Ci-20-alkoxy, wherein

Z 18 at each occurrence is a covalent bond, wherein,

M 1 , M 2 and M 3 can be the same or different and are S, O, NH or SiRtR*, preferably M 1 , M 2 are S or NH, and M 3 is S, O, NH or SiR'R 1 , more preferably M 1 and M 2 are S, and M 3 is NH or SiR'R',

wherein R* is H or Ci-30-alkyl, or L is

wherein

R 23 and R 24 are the same or different and are H, Ci-30-alkyl, Ci-30-haloalkyl, -X 7 -R 25 or -X 8 -Ar 13 ,

wherein

X 7 at each occurrence is independently -[Z 19 -0] c -, -[Z 19 -S-] c -, or -[S-Z 19 ] c -S-, wherein

Z 19 at each occurrence is independently Ci-6-alkylene or Ci-6-haloalkylene, c at each occurrence is independently an integer from 1 to 10 and

R 25 at each occurrence is independently Ci-30-alkyl or Ci-30-haloalkyl,

X 8 at each occurrence is independently -Z 21 -0-Z 22 -, -Z 21 -S-Z 22 -, Ci-30-alkylene or Ci-3o-haloalkylene,

wherein

Z 21 and Z 22 at each occurrence are independently Ci-6-alkylene or

Ci-6-haloalkylene, and

Ar 13 at each occurrence is independently C6-i4-aryl, optionally substituted with 1 to 5 substituents R°, wherein each R° is independently selected from the group consisting of halogen Ci-6-alkyl and Ci-6-alkoxy.

Even more preferably,

L is is a bivalent 5 to 18 membered aromatic heterocyclic residue selected from the group consisting of

wherein the bivalent 5 to 18 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R, wherein each wherein each R R is independently selected from the group consisting of Ci-30-alkyl and -Z 18 -C6-i4-aryl, wherein Ci-30-alkyl and C6-i4-aryl are optionally substituted with 1 to 4 substituents R m , wherein each R m is independently selected from the group consisting of halogen, -CN and *=0, and wherein C6-i4-aryl is optionally substituted with 1 to 4 substituents R n , wherein each R n is independently selected from the group consisting of Ci-20-alkyl and Ci-20-alkoxy, wherein

Z 18 at each occurrence is a covalent bond, wherein R* is hydrogen or Ci or L is

wherein

R 23 and R 24 are the same or different and are H, Ci-30-alkyl, Ci-30-haloalkyl, -X 7 -R 25 or -X 8 -Ar 13 ,

wherein

X 7 at each occurrence is independently -[Z 19 -0] c -, -[Z 19 -S-] c -, or -[S-Z 19 ] c -S-, wherein

Z 19 at each occurrence is independently Ci-6-alkylene or Ci-6-haloalkylene, c at each occurrence is independently an integer from 1 to 10 and

R 25 at each occurrence is independently Ci-30-alkyl or Ci-30-haloalkyl,

X 8 at each occurrence is independently -Z 21 -0-Z 22 -, -Z 21 -S-Z 22 -, Ci-30-alkylene or Ci-3o-haloalkylene,

wherein

Z 21 and Z 22 at each occurrence are independently Ci-6-alkylene or

Ci-6-haloalkylene, and

Ar 13 at each occurrence is independently C6-i4-aryl, optionally substituted with 1 to 5 substituents R°, wherein each R° is independently selected from the group consisting of halogen Ci-6-alkyl and Ci-6-alkoxy.

Even more preferably,

L is is a bivalent 5 to 18 membered aromatic heterocyclic residue selected from the group consisting of

wherein the bivalent 5 to 18 membered aromatic heterocyclic residue is optionally sub- stituted with 1 to 4 substituents R, wherein each R R is independently selected from the group consisting of Ci-30-alkyl and -Z 18 -C6-i4-aryl, wherein Ci-30-alkyl and C6-i4-aryl are optionally substituted with 1 to 4 substituents R m , wherein each R m is independently selected from the group consisting of halogen, -CN and *=0, and wherein C6-i4-aryl is optionally substituted with 1 to 4 substituents R n , wherein each R n is independently selected from the group consisting of Ci-20-alkyl and Ci-20-alkoxy, wherein

Z 18 at each occurrence is a covalent bond, wherein R* is hydrogen or Ci-30-alkyl, or L is

wherein

R 23 and R 24 are the same or different and are H, Ci-30-alkyl, Ci-30-haloalkyl, -X 7 -R 25 or -X 8 -Ar 13 ,

wherein

X 7 at each occurrence is independently -[Z 19 -0] c -, -[Z 19 -S-] c -, or -[S-Z 19 ] c -S-, wherein

Z 19 at each occurrence is independently Ci-6-alkylene or Ci-6-haloalkylene, c at each occurrence is independently an integer from 1 to 10 and

R 25 at each occurrence is independently Ci-30-alkyl or Ci-30-haloalkyl,

X 8 at each occurrence is independently -Z 21 -0-Z 22 -, -Z 21 -S-Z 22 -, Ci-30-alkylene or Ci-3o-haloalkylene,

wherein

Z 21 and Z 22 at each occurrence are independently Ci-6-alkylene or

Ci-6-haloalkylene, and

Ar 13 at each occurrence is independently C6-i4-aryl, optionally substituted with 1 to 5 substituents R°, wherein each R° is independently selected from the group consisting of halogen Ci-6-alkyl and Ci-6-alkoxy.

Most preferably,

L is

wherein each R is independently Ci-30-alkyl, preferably n-octyl, n-(2-ethyl)hexyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, n-undecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl, n-nonadecyl and n-icosyl (C20), more preferably, n-hexadecyl, or

L is

wherein

R 23 and R 24 are the same or different and are H, Ci-30-alkyl or Ci-30-haloalkyl, in particu- lar H.

Preferably, q, r and s are 0 or 1 , with the proviso that q, r and s are not all 0 at the same time.

Preferably, n is an integer from 1 to 5000, 1 to 1000, 1 to 100, 1 to 50 or from 1 to 30, for example n can be an integer from 2 to 5000, 2 to 1000, 2 to 50, 2 to 30. In some embodiments, n can be an integer from 4 to 1000, 4 to 100, 8 to 1000 or 8 to 100.

In one embodiment,

A 1 and A 2 are S,

E is

wherein

R 1 and R 2 are the same or different and are H, Ci-30-alkyl, Ci-30-haloalkyl, -X 1 -R 6 or

-X 2 -Ar 1 ,

wherein

X 1 at each occurrence is independently -[Z 1 -0] a -, -[Z 1 -S-] a -, or -[S-Z 1 ] a -S-,

wherein

Z 1 at each occurrence is independently Ci-6-alkylene or Ci-6-haloalkylene, a at each occurrence is independently an integer from 1 to 10 and R 6 at each occurrence is independently Ci-30-alkyl or Ci-30-haloalkyl,

X 2 at each occurrence is independently -Z 3 -0-Z 4 -, -Z 3 -S-Z 4 -, Ci-30-alkylene or Ci-3o-haloalkylene,

wherein

Z 3 and Z 4 at each occurrence are independently Ci-6-alkylene or

Ci-6-haloalkylene, and

Ar 1 at each occurrence is independently C6-i4-aryl, optionally substituted with 1 to 5 substituents R a , wherein each R a is independently selected from the group consisting of halogen Ci-6-alkyl and Ci-6-alkoxy.

L is a bivalent 5 to 18 membered aromatic heterocyclic residue, wherein the bivalent 5 to 18 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of Ci-3o-alkyl, -Z 18 -O-Ci- 30 -alkyl, -Z 18 -S-Ci- 30 -alkyl, -Z 18 -C 3 -io-cycloalkyl, -Z 18 -C 6 -i 4 -aryl, -Z 18 -monovalent 3 to 12 membered aliphatic heterocyclic residue and -Z 18 -monovalent 5 to 14 membered aromatic heterocyclic residue, wherein Ci-30-alkyl, C3-io-cycloalkyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R m , wherein each R m is independently selected from the group consisting of halogen, -CN and *=0, and wherein C3-io-cycloalkyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R n , wherein each R n is independently selected from the group consisting of Ci-20-alkyl, Ci-20-alkoxy, Ci-20-haloalkyl, wherein

Z 18 at each occurrence is independently Ci-6-alkylene, Ci-6-haloalkylene or a cova- lent bond, q and s are 0, r is 1 , and n is an integer from 1 to 1000, preferably 4 to 100. In a second embodiment,

A 1 and A 2 are S,

E is

wherein

R 1 and R 2 are the same or different and are H, Ci-30-alkyl, Ci-30-haloalkyl, -X 1 -R 6 or -X 2 -Ar 1 ,

wherein

X 1 at each occurrence is independently -[Z 1 -0] a -, -[Z 1 -S-] a -, or -[S-Z 1 ] a -S-,

wherein

Z 1 at each occurrence is independently Ci-6-alkylene or Ci-6-haloalkylene, a at each occurrence is independently an integer from 1 to 10 and

R 6 at each occurrence is independently Ci-30-alkyl or Ci-30-haloalkyl,

X 2 at each occurrence is independently -Z 3 -0-Z 4 -, -Z 3 -S-Z 4 -, Ci-30-alkylene or Ci-3o-haloalkylene,

wherein

Z 3 and Z 4 at each occurrence are independently Ci-6-alkylene or

Ci-6-haloalkylene, and Ar 1 at each occurrence is independently C6-i4-aryl, optionally substituted with 1 to

5 substituents R a , wherein each R a is independently selected from the group consisting of halogen Ci-6-alkyl and Ci-6-alkoxy,

G 1 and G 2 are the same or different and are phenylene such as or, preferably, a monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue selected from the group consisting of which phenylene or monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue are optionally substituted with 1 to 2 substituents R, wherein each R is independently selected from the group consisting of Ci-30-alkyl, -Z 17 -0-Ci-3o-alkyl, -Z 17 -S-Ci-3o-alkyl, -Z 17 -C3-io-cycloalkyl, -Z 17 -C6-i4-aryl, -Z 17 -monovalent 3 to 12 membered aliphatic het- erocyclic residue and -Z 17 -monovalent 5 to 14 membered aromatic heterocyclic residue, wherein Ci-30-alkyl, C3-io-cycloalkyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of halogen, -CN and *=0, and wherein C3-io-cycloalkyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R k , wherein each R k is independently selected from the group consisting of Ci-20-alkyl, Ci-20-alkoxy, Ci-20-haloalkyl, wherein

Z 17 at each occurrence is independently Ci-6-alkylene, Ci-6-haloalkylene or a cova- lent bond.

L is

wherein

R 23 and R 24 are the same or different and are H, Ci-30-alkyl, Ci-30-haloalkyl, -X 7 -R 25 or -X 8 -Ar 13 ,

wherein

X 7 at each occurrence is independently -[Z 19 -0] c -, -[Z 19 -S-] c -, or -[S-Z 19 ] c -S-, wherein

Z 19 at each occurrence is independently Ci-6-alkylene or Ci-6-haloalkylene, c at each occurrence is independently an integer from 1 to 10 and

R 25 at each occurrence is independently Ci-30-alkyl or Ci-30-haloalkyl,

X 8 at each occurrence is independently -Z 21 -0-Z 22 -, -Z 21 -S-Z 22 -, Ci-30-alkylene or Ci-3o-haloalkylene,

wherein Z 21 and Z 22 at each occurrence are independently Ci-6-alkylene or

Ci-6-haloalkylene, and

Ar 13 at each occurrence is independently C6-i4-aryl, optionally substituted with 1 to 5 substituents R°, wherein each R° is independently selected from the group consisting of halogen Ci-6-alkyl and Ci-6-alkoxy, q and s are 1 , r is 1 , and n is an integer from 1 to 1000, preferably from 2 to 50.

In a third embodiment,

A 1 and A 2 are S, E is

wherein

R 1 and R 2 are the same or different and are H, Ci-30-alkyl, Ci-30-haloalkyl, -X 1 -R 6 or -X 2 -Ar 1 ,

wherein

X 1 at each occurrence is independently -[Z 1 -0] a -, -[Z 1 -S-] a -, or -[S-Z 1 ] a -S-,

wherein

Z 1 at each occurrence is independently Ci-6-alkylene or Ci-6-haloalkylene, a at each occurrence is independently an integer from 1 to 10 and

R 6 at each occurrence is independently Ci-30-alkyl or Ci-30-haloalkyl, X 2 at each occurrence is independently -Z 3 -0-Z 4 -, -Z 3 -S-Z 4 -, Ci-30-alkylene or

Ci-3o-haloalkylene,

wherein

Z 3 and Z 4 at each occurrence are independently Ci-6-alkylene or

Ci-6-haloalkylene, and Ar 1 at each occurrence is independently C6-i4-aryl, optionally substituted with 1 to 5 substituents R a , wherein each R a is independently selected from the group consisting of halogen Ci-6-alkyl and Ci-6-alkoxy,

G 1 and G 2 are the same or different and are phenylene such as or, preferably, a monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue selected from the group consisting of which phenylene or monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue are optionally substituted with 1 to 2 substituents R, wherein each R is independently selected from the group consisting of Ci-30-alkyl, -Z 17 -0-Ci-3o-alkyl, -Z 17 -S-Ci-3o-alkyl, -Z 17 -C3-io-cycloalkyl, -Z 17 -C6-i4-aryl, -Z 17 -monovalent 3 to 12 membered aliphatic heterocyclic residue and -Z 17 -monovalent 5 to 14 membered aromatic heterocyclic resi- due, wherein Ci-30-alkyl, C3-io-cycloalkyl, C6-i4-aryl, monovalent s to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of halogen, -CN and *=0, and wherein C3-io-cycloalkyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R k , wherein each R k is independently selected from the group consisting of Ci-20-alkyl, Ci-20-alkoxy, Ci-20-haloalkyl, wherein

Z 17 at each occurrence is independently Ci-6-alkylene, Ci-6-haloalkylene or a cova- lent bond, q and s are 1 , r is 0, and n is an integer from 1 to 1000, preferably from 1 to 30.

In a fourth embodiment,

A 1 and A 2 are S,

E is

R 3

N

/ \

* * wherein

R3 is -X 5 -Ar 7 , -X 5 -Ar 8 -Ar 7 , -X 5 -Ar 8 -R 13 or -X 5 -Ar 8 -Ar 9 -R 13 ,

wherein

X 5 at each occurrence is a covalent bond,

Ar 7 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R e , wherein each R e is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 8 and Ar 9 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R f , wherein each R f is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R 13 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl, Ci-20-haloalkyl or Ci-2o-alkoxy,

G 1 and G 2 are the same or different and are phenylene such as or, preferably, a monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue selected from the group consisting of which phenylene or monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue are optionally substituted with 1 to 2 substituents R, wherein each R is independently selected from the group consisting of Ci-30-alkyl, -Z 17 -0-Ci-3o-alkyl, -Z 17 -S-Ci-3o-alkyl, -Z 17 -C3-io-cycloalkyl, -Z 17 -C6-i4-aryl, -Z 17 -monovalent 3 to 12 membered aliphatic heterocyclic residue and -Z 17 -monovalent 5 to 14 membered aromatic heterocyclic residue, wherein Ci-30-alkyl, C3-io-cycloalkyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of halogen, -CN and *=0, and wherein C3-io-cycloalkyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R k , wherein each R k is independently selected from the group consisting of Ci-20-alkyl, Ci-20-alkoxy, Ci-20-haloalkyl, wherein

Z 17 at each occurrence is independently Ci-6-alkylene, Ci-6-haloalkylene or a cova- lent bond,

L is

wherein

R 23 and R 24 are the same or different and are H, Ci-30-alkyl, Ci-30-haloalkyl, -X 7 -R 25 or -X 8 -Ar 13 ,

wherein

X 7 at each occurrence is independently -[Z 19 -0] c -, -[Z 19 -S-] c -, or -[S-Z 19 ] c -S-, wherein

Z 19 at each occurrence is independently Ci-6-alkylene or Ci-6-haloalkylene, c at each occurrence is independently an integer from 1 to 10 and

R 25 at each occurrence is independently Ci-30-alkyl or Ci-30-haloalkyl,

X 8 at each occurrence is independently -Z 21 -0-Z 22 -, -Z 21 -S-Z 22 -, Ci-30-alkylene or Ci-3o-haloalkylene, wherein

Z 21 and TP- at each occurrence are independently Ci-6-alkylene or

Ci-6-haloalkylene, and Ar 13 at each occurrence is independently C6-i4-aryl, optionally substituted with

1 to 5 substituents R°, wherein each R° is independently selected from the group consisting of halogen Ci-6-alkyl and Ci-6-alkoxy, q and s are 1 , r is 1 , and n is an integer from 1 to 1000, preferably from 2 to 50.

Examples of compounds, oligomers or polymers of formula 1 are

and

wherein n is an integer from 1 to 1000, preferably 1 to 100, 1 to 50 or from 1 to 30, for example n can be an integer from 2 to 1000, 2 to 100, 2 to 50, 2 to 30, or an integer from 4 to 100 or 8 to 100.

Also part of the present invention is a process for the preparation of the compound, oligomer or polymer of formula wherein

A 1 and A 2 can be the same or different and are S or Se, E is selected from the group consisting of

wherein

R 1 and R 2 can be the same or different and are H, halogen, -CN , Ci-30-alkyl, C2-3o-alkenyl, C2- 2 o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, Ce-io-cycloalkynyl, Ci-3o-haloalkyl, monovalent 3 to 12 membered aliphatic heterocyclic residue, -X 1 -R 6 , -X 2 -Ar 1 , -X 2 -Ar 2 -Ar 1 , -X 2 -Ar 2 -R 7 or -X 2 -Ar 2 -Ar 3 -R 7 ,

wherein X 1 at each occurrence is independently -0-, -[Z 1 -0] a -, -[0-Z 1 ] a -0-, -S-, -[Z 1 -S-] a -, -[S-ZVS-, -S(O), -C(O)-, -C(0)0-, -C(0)NR 8 -, C(0)S-, -O(CO)-, -S(CO)-, -NR 8 C(0)- or -NR 8 -,

wherein

Z 1 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or

Ci-6-haloalkylene,

a at each occurrence is independently an integer from 1 to 10 and

R 8 at each occurrence is independently H, Ci-2o-alkyl, or -Z 2 -C6-i4-aryl, wherein

Z 2 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene,

Ci-6-haloalkylene or a covalent bond,

R 6 at each occurrence is independently Ci-3o-alkyl, C2-3o-alkenyl or Ci-3o-haloalkyl, X 2 at each occurrence is independently -Z 3 -0-Z 4 -, -Z 3 -S-Z 4 -, -S(O)-, -C(O)-,

-C(0)0-, -(CO)NR 9 , -C(0)S-, -O(CO)-, -S(CO)-, -NR 9 C(0)-, -NR 9 -, -Z 3 -SiR 9 2 -Z 4 -, Ci-3o-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a covalent bond,

wherein

Z 3 and Z 4 at each occurrence are independently Ci-6-alkylene, C2-6-alkenyl- ene, Ci-6-haloalkylene or a covalent bond, and

R 9 at each occurrence is independently H, Ci-2o-alkyl, or -Z 5 -C6-i4-aryl,

wherein

Z 5 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

Ar 1 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 sub- stituents R a , wherein each R a is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 2 and Ar 3 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R b , wherein each R b is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R 7 at each occurrence is independently Ci-2o-alkyl, C2-2o-alkenyl, Ci-2o-haloalkyl, Ci-2o-alkoxy, -X 3 -Ar 4 , -X 3 -Ar 5 -Ar 4 , -X 3 -Ar 5 -R 10 , or -X S -Ar S -Are-R 10 ,

wherein

X 3 at each occurrence is independently -Z 6 -0-Z 7 -, -Z 6 -S-Z 7 , -S(O)-, -C(O)-, -C(0)0-, -(CO)NR 11 , -C(0)S-, -O(CO)-, -S(CO)-, -NR 11 C(0)-, -NR 11 -,

-Z 6 -SiR 1 1 2-Z 7 -, Ci-3o-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a covalent bond,

wherein Z 6 and Z 7 at each occurrence are independently Ci-6-alkylene,

C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and

R 11 at each occurrence is independently H, Ci-20-alkyl or -Z 8 -C6-i4-aryl, wherein

Z 8 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene,

Ci-6-haloalkylene or a covalent bond,

Ar 4 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R c , wherein each R c is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 5 and Ar 6 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R d , wherein each R d is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R 10 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl,

Ci-2o-haloalkyl or Ci-20-alkoxy,

R 3 , R 4 and R 5 can be the same or different and are H, halogen, -CN , Ci-30-alkyl, C 2 - 3o-alkenyl, C2- 2 o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, Ce-io-cycloalkynyl,

Ci-: 3o-haloalkyl, monovalent 3 to 12 membered aliphatic heterocyclic residue,

-X 4 -R 12 , -X 5 -Ar 7 , -X 5 -Ar 8 -Ar 7 , -X 5 -Ar 8 -R 13 or -X 5 -Ar 8 -Ar 9 -R 13 ,

wherein

X 4 at each occurrence is independently -[Z 9 -0] b -, -[Z 9 -S-] b -, -S(O)-, -C(O)-, -C(0)0-, -C(0)N R 14 - or C(0)S-,

wherein

Z 9 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or Ci-6-haloalkylene,

b at each occurrence is independently an integer from 1 to 10 and

R 14 at each occurrence is independently H, Ci-20-alkyl, or -Z 10 -C6-i4-aryl, wherein

Z 10 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

R 12 at each occurrence is independently Ci-30-alkyl, C2-3o-alkenyl or

Ci-3o-haloalkyl,

X 5 at each occurrence is independently -Z 11 -0-Z 12 , -Z 11 -S-Z 12 -, -S(O)-, -C(O)-, -C(0)0-, -(CO)NR 15 , -C(0)S-, -Z 11 -SiR 1 5 2-Z 12 -, Ci- 30 -alkylene, C 2 - 30 -alkenylene, Ci-3o-haloalkylene or a covalent bond, wherein

Z 11 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or Ci-6-haloalkylene,

Z 12 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and

R 15 at each occurrence is independently H, Ci-20-alkyl, or -Z 13 -C6-i4-aryl, wherein

Z 13 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

Ar 7 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R e , wherein each R e is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 8 and Ar 9 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R f , wherein each R f is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl and

R 13 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl, Ci-20-haloalkyl, Ci-2o-alkoxy, -X 6 -Ar 10 , -X 6 -Ar 11 -Ar 10 , -X 6 -Ar 11 -R 16 , or -X 6 -Ar 11 -Ar 12 -R 17 ,

wherein

X 6 at each occurrence is independently -Z 14 -0-Z 15 -, -Z 14 -S-Z 15 , -S(O)-, -C(O)-, -C(0)0-, -(CO)NR 18 , -C(0)S-, -O(CO)-, -S(CO)-, -N R 18 C(0)-, -N R 18 -,

-Z 14 -SiR 18 2-Z 15 -, Ci-3o-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a covalent bond,

wherein

Z 14 and Z 15 at each occurrence are independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and

R 18 at each occurrence is independently H, Ci-20-alkyl or -Z 16 -C 6 -i4-aryl, wherein

Z 16 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

Ar 10 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R9, wherein each Ra is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 11 and Ar 12 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R h , wherein each R h is independently selected from the group consisting of halogen, CN , Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl and

R 17 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl, Ci-20-haloalkyl or Ci-2o-alkoxy,

R 19 is O or C(CN) 2 , and

R 20 and R 21 are the same or different and are R 22 or CN,

wherein R 22 has the same meaning as R 1 ,

G 1 and G 2 are the same or different and are phenylene or a monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue, which phenylene and monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue are optionally substituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of halogen, -CN, -N0 2 , OH, Ci- 30 -alkyl, C 2 - 30 -alkenyl, C 2 - 30 -alkynyl, -Z 17 -O-Ci- 30 -alkyl, -Z 17 -S-Ci- 3 o-alkyl, -Z 17 -C 3 -io-cycloalkyl, -Z 17 -Cs-io-cycloalkenyl, -Z 17 -C8-io-cycloalkynyl, -Z 17 -C6-i4-aryl, -Z 17 -monovalent 3 to 12 membered aliphatic heterocyclic residue and -Z 17 -monovalent 5 to 14 membered aromatic heterocyclic residue, wherein Ci- 3 o-alkyl, C2- 3 o-alkenyl, C2- 3 o-alkynyl, C 3 -io-cycloalkyl, Cs-io-cycloalkenyl, Ce-io-cycloalkynyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally sub- stituted with 1 to 4 substituents R, wherein each R is independently selected from the group consisting of halogen, -CN, -NO2, *=0, -OH, -NH 2 , -NH(Ci-2o-alkyl),

-N(Ci-2o-alkyl) 2 , -N(Ci- 2 o-alkyl)-C 6 -i4-aryl, -N(C 6 -i4-aryl) 2 , -S(0) m H, -S(O) m -Ci- 20 -alkyl, -S(0) 2 OH, -S(0)m-OCi-2o-alkyl, -S(0) m -OC 6 -i4-aryl, -CHO, -C(O)-Ci- 20 -alkyl,

-C(0)-C 6 -i4-aryl, -C(0)OH, -C(O)-OCi- 20 -alkyl, -C(0)-OC 6 -i 4 -aryl, -C(0)NH 2 ,

-C(O)NH-Ci- 20 -alkyl, -C(O)N(Ci- 20 -alkyl) 2 , -C(0)NH-C 6 -i 4 -aryl,

-C(O)N(Ci-2 0 -alkyl)-C 6 -i4-aryl, -C(0)N(C 6 -i4-aryl) 2 , -C(S)NH 2 , -C(S)NH-Ci- 20 -alkyl, -C(S)N(Ci-2o-alkyl) 2 , -C(S)N(C 6 -i4-aryl) 2 , -C(S)N(Ci- 20 -alkyl)-C 6 -i4-aryl,

-C(S)NH-C 6 -i4-aryl, -S(0) m NH 2 , -S(O) m NH(Ci- 20 -alkyl), -S(0) m N(Ci- 2 o-alkyl) 2 ,

-S(0)mNH(C 6 -i4-aryl), -S(0) m N(Ci-2o-alkyl)-C 6 -i4-aryl, -S(0) m N(C 6 -i4-aryl)2, SiH 3 , SiH(Ci-2o-alkyl) 2 , SiH 2 (Ci- 20 -alkyl) and Si(Ci- 20 -alkyl) 3 , and wherein C 3 -io-cycloalkyl, Cs-io-cycloalkenyl, -Ce-io-cycloalkynyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R k , wherein each R k is independently selected from the group consisting of Ci-20-alkyl, C2-2o-alkenyl, C2- 2 o-alkynyl, Ci-20-alkoxy, -S-Ci-20-alkyl, Ci-20-haloalkyl, wherein Z 17 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene,

Ci-6-haloalkylene or a covalent bond, and

m at each occurrence is independently 0, 1 or 2,

L is C6-24-arylene or a bivalent 5 to 18 membered aromatic heterocyclic residue, wherein C6-24-arylene and bivalent 5 to 18 membered aromatic heterocyclic residue are optionally substituted with 1 to 4 substituents R', wherein each R is independently selected from the group consisting of halogen, -CN, -NO2, *=0, OH, *=C(Ci-3o-alkyl) 2 , Ci-3o-alkyl, C 2 - 3 o-alkenyl, C 2 - 30 -alkynyl, -Z 18 -O-Ci- 30 -alkyl, -Z 18 -S-Ci- 30 -alkyl,

-Z 18 -C 3 -io-cycloalkyl, -Z 18 -Cs-io-cycloalkenyl, -Z 18 -C8-io-cycloalkynyl, -Z 18 -C6-i4-aryl, -Z 18 -monovalent 3 to 12 membered aliphatic heterocyclic residue and -Z 18 -monovalent 5 to 14 membered aromatic heterocyclic residue, wherein Ci- 3 o-alkyl, C2- 3 o-alkenyl, C2- 3 o-alkynyl, C 3 -io-cycloalkyl, Cs-io-cycloalkenyl,

Ce-io-cycloalkynyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R m , wherein each R m is independently selected from the group consisting of halogen, -CN, -NO2, *=0, -OH, -NH 2 , -NH(Ci-2o-alkyl),

-N(Ci-2o-alkyl) 2 , -N(Ci- 20 -alkyl)-C 6 -i4-aryl, -N(C 6 -i4-aryl) 2 , -S(0) 0 H, -S(O) o -Ci- 20 -alkyl, -S(0) 2 OH, -S(0) 0 -OCi-2o-alkyl, -S(0) 0 -OC 6 -i 4 -aryl, -CHO, -C(O)-Ci- 20 -alkyl,

-C(0)-C 6 -i4-aryl, -C(0)OH, -C(O)-OCi- 20 -alkyl, -C(0)-OC 6 -i 4 -aryl, -C(0)NH 2 ,

-C(O)NH-Ci- 20 -alkyl, -C(O)N(Ci- 20 -alkyl) 2 , -C(0)NH-C 6 -i 4 -aryl,

-C(O)N(Ci-2 0 -alkyl)-C 6 -i4-aryl, -C(0)N(C 6 -i4-aryl) 2 , -C(S)NH 2 , -C(S)NH-Ci- 20 -alkyl, -C(S)N(Ci-2o-alkyl) 2 , -C(S)N(C 6 -i4-aryl) 2 , -C(S)N(Ci- 2 o-alkyl)-C 6 -i4-aryl,

-C(S)NH-C 6 -i4-aryl, -S(0) 0 NH 2 , -S(O) o NH(Ci- 20 -alkyl), -S(0) 0 N(Ci-2o-alkyl) 2 ,

-S(0) 0 NH(C 6 -i4-aryl), -S(O) o N(Ci-2 0 -alkyl)-C 6 -i4-aryl, -S(0) 0 N(C 6 -i4-aryl) 2 , SiH 3 ,

SiH(Ci-2o-alkyl) 2 , SiH 2 (Ci- 20 -alkyl) and Si(Ci- 20 -alkyl) 3 , and wherein C 3 -io-cycloalkyl, Cs-io-cycloalkenyl, -Ce-io-cycloalkynyl, C6-i4-aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R n , wherein each R n is independently selected from the group consisting of Ci-20-alkyl, C2-2o-alkenyl, C2- 2 o-alkynyl, Ci-20-alkoxy, -S-Ci-20-alkyl, Ci-20-haloalkyl, wherein

Z 18 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene,

Ci-6-haloalkylene or a covalent bond, and

o at each occurrence is independently 0, 1 or 2, wherein

R 23 and R 24 can be the same or different and are H, halogen, -CN , Ci-30-alkyl,

C2-3o-alkenyl, C2- 2 o-alkynyl, C3-io-cycloalkyl, Cs-io-cycloalkenyl, Ce-io-cycloalkynyl, Ci-3o-haloalkyl, monovalent 3 to 12 membered aliphatic heterocyclic residue, -X 7 -R 25 , -X 8 -Ar 13 , -X 8 -Ar 14 -Ar 13 , -X 8 -Ar 14 -R 26 or -X 8 -Ar 14 -Ar 15 -R 26 ,

wherein

X 7 at each occurrence is independently -0-, -[Z 19 -0] c -, -[0-Z 19 ] c -0-, -S-, -[Z 19 -S-] c -

, -[S-Z 19 ]c-S-, -S(O), -C(O)-, -C(0)0-, -C(0)NR 27 -, C(0)S-, -O(CO)-, -S(CO)-, -NR 27 C(0)- or -NR 27 -,

wherein

Z 19 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene or Ci-6-haloalkylene,

c at each occurrence is independently an integer from 1 to 10 and

R 27 at each occurrence is independently H, Ci-20-alkyl, or -Z 20 -C6-i4-aryl, wherein

Z 20 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

R 25 at each occurrence is independently Ci-30-alkyl, C2-3o-alkenyl or

Ci-3o-haloalkyl, X 8 at each occurrence is independently -Z 21 -0-Z 22 -, -Z 21 -S-Z 22 -, -S(O)-, -C(O)-,

-C(0)0-, -(CO)NR 28 , -C(0)S-, -O(CO)-, -S(CO)-, -NR 28 C(0)-, -NR 28 -,

-Z 21 -SiR 28 2-Z 22 -, Ci-3o-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a covalent bond,

wherein

Z 21 and Z 22 at each occurrence are independently Ci-6-alkylene, C2-6-alkenyl- ene, Ci-6-haloalkylene or a covalent bond, and

R 28 at each occurrence is independently H, Ci-20-alkyl, or -Z 23 -C6-i4-aryl, wherein

Z 23 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

Ar 12 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 membered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 sub- stituents R°, wherein each R° is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 14 and Ar 15 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to

4 substituents RP, wherein each RP is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R 26 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl, Ci-20-haloalkyl, Ci-2o-alkoxy, -X 9 -Ar 16 , -X 9 -Ar 17 -Ar 16 , -X 9 -Ar 17 -R 29 , or -X 9 -Ar 17 -Ar 18 -R 29 ,

wherein

X 9 at each occurrence is independently -Z 24 -0-Z 25 -, -Z 24 -S-Z 25 , -S(O)-, -C(O)-, -C(0)0-, -(CO)NR 30 , -C(0)S-, -O(CO)-, -S(CO)-, -NR 30 C(O)-, -NR 30 -,

-Z 24 -SiR 30 2-Z 25 -, Ci-3o-alkylene, C2-3o-alkenylene, Ci-30-haloalkylene or a cova- lent bond,

wherein

Z 24 and Z 25 at each occurrence are independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond, and

R 30 at each occurrence is independently H, Ci-20-alkyl or -Z 26 -C 6 -i4-aryl, wherein

Z 26 at each occurrence is independently Ci-6-alkylene, C2-6-alkenylene, Ci-6-haloalkylene or a covalent bond,

Ar 16 at each occurrence is independently C6-i4-aryl or monovalent 5 to 14 mem- bered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R q , wherein each R^ is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl,

Ar 17 and Ar 18 at each occurrence are independently C6-i4-arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to

4 substituents R r , wherein each R r is independently selected from the group consisting of halogen, CN, Ci-6-alkyl, Ci-6-alkoxy and Ci-6-haloalkyl, and

R 29 at each occurrence is independently Ci-20-alkyl, C2- 2 o-alkenyl, Ci-20-haloalkyl or Ci-2o-alkoxy, q and s are the same or different and are 0, 1 , 2, 3, 4 or 5, r is 0, 1 or 2, and n is an integer from 1 to 10Ό00, which process comprises

preferably, (i) the step of reacting a compound of formula wherein A 1 , A 2 and E are as defined above, and Hal is halogen, preferably -Br, with a compound of formula wherein G 1 , G 2 , L, q, r, and s are as defined above, and R 31 , R 32 , R 33 , R 34 , R 35 and R 36 are the same and are Ci-30-alkyl, preferably Ci-6-alkyl, most preferably n-butyl or methyl, in the presence of a metal catalyst, or

(ii) the step of of reacting a compound of formula wherein A 1 , A 2 and E, G 1 , G 2 , r and s are as defined above, and Hal is halogen, preferably -Br, with a compound of formula wherein L and r are as defined above, and R 31 , R 32 , R 33 , R 34 , R 35 and R 36 are the same and are Ci-30-alkyl, preferably Ci-6-alkyl, most preferably n-butyl or methyl, in the presence of a metal catalyst, or

(iii) the step of reacting a compound of formula

wherein A 1 , A 2 and E are as defined above, and R 31 , R 32 , R 33 , R 34 , R 35 and R 36 are the same and are Ci-30-alkyl, preferably Ci-6-alkyl, most preferably n-butyl or methyl, with a compound of formula wherein G 1 , G 2 , L, q, r, and s are as defined above, and Hal is halogen, preferably -Br, in the presence of a metal catalyst, or (iv) the step of of reacting a compound of formula wherein A 1 , A 2 , E, G 1 , G 2 , r and s are as defined above, and and R 31 , R 32 , R 33 , R 34 , R 35 and R 36 are the same and are Ci-30-alkyl, preferably Ci-6-alkyl, most preferably n-butyl or methyl, with a compound of formula Hal^(" L ^Hal (13) wherein L and r are as defined above, and Hal is halogen, preferably -Br, in the presence of a metal catalyst.

Preferably R 31 , R 32 , R 33 , R 34 , R 35 and R 36 are methyl or n-butyl. The metal catalyst is preferably a palladium catalyst such tris(dibenzylideneacetone)- dipalladium(O), preferably in combination with a phosphine such as tri-o-tolylphosphine. The reaction is preferably performed at elevated temperatures such 80 to 200 °C, preferably 90 to 150 °C. The reaction can be performed in an inert organic solvent such as chlorobenzene. The reaction can be stopped by the addition of end cappers such as 2-bromothiophene and 2-tributylstannylthiophene. The crude product may be worked up by conventional merthods, for example by extracting the crude product with an appropriate solvent, for example with acetone.

Alternatively, the compound, oligomer or polymer of formula wherein A 1 , A 2 , E, G 1 , L, G 2 , q, r, s and n are as defined above, can be prepared by the process as outlined above but using wherein G 1 , G 2 , L, q, r, and s are as defined above, and R 37 , R 38 , R 39 and R 40 are the same and are H or Ci-30-alkyl, or R 37 and R 38 , respectively, R 39 and R 40 form together with -0-B-O- a 5 to 8-membered cyclic ring, for example a pinacol type ring of formula instead of the compound of formula 3, wherein L and r are as defined above, and R 37 , R 38 , R 39 and R 40 are the same and are H or Ci-30-alkyl, or R 37 and R 38 , respectively, R 39 and R 40 form together with -0-B-O- a 5 to 8-membered cyclic ring, for example a pinacol type ring of formula instead of the compound of formula 9,

wherein A 1 , A 2 and E are as defined above, and R 37 , R 38 , R 39 and R 40 are the same and are H or Ci-30-alkyl, or R 37 and R 38 , respectively, R 39 and R 40 form together with -O-B- O- a 5 to 8-membered cyclic ring, for example a pinacol type ring of formula instead of the compound of formula 10, or

wherein A 1 , A 2 , E, G 1 , G 2 , r and s are as defined above, and and R 37 , R 38 , R 39 and R 40 are the same and are H or Ci-30-alkyl, or R 37 and R 38 , respectively, R 39 and R 40 form together with -0-B-O- a 5 to 8-membered cyclic ring, for example a pinacol type ring of formula instead of the compound of formula 12.

The compound of formula

(2)

wherein A 1 and A 2 are as defined above, and Hal is halogen, preferably -Br, and E is

wherein R 1 , R 2 and R 3 are as defined above, can be prepared by a process, which comprises the step of reacting a compound of formula

wherein A 1 , A 2 and E are as defined above, and R 41 , R 42 , R 43 , R 44 , R 45 and R 46 are Ci-3o-alkyl, preferably Ci-6-alkyl, more preferably isopropyl, with a halogenating agent in the presence of an acidic catalyst.

The halogenating agent is preferably Br2. The acidic catalyst is preferably trichloroacetic acid. The reaction is preferably carried out in an inert organic solvent such as chloroform. The reaction is preferably carried out at ambient temperature, for example at a temperature from 15 to 30 °C, more preferably at a temperature from 18 to 26 °C. The reaction mixture can be worked up by conventional methods.

The compound of formula

wherein A 1 , A 2 and E are as defined above, and R 41 , R 42 , R 43 , R 44 , R 45 and R 46 are Ci-3o-alkyl, preferably Ci-6-alkyl, more preferably isopropyl, can be prepared by a process, which comprises the step of coupling a compound of formula

wherein A 1 , A 2 , R 41 , R 42 , R 43 , R 44 , R 45 and R 46 are as defined above, and Hal is halogen, preferably -Br, with H-E-H or wherein R 47 , R 48 , R 49 and R 50 are the same and are H or Ci- 3 o-alkyl, or R 47 and R 48 , respectively, R 49 and R 50 form together with -0-B-O- a 5 to 8-membered cyclic ring, for example a pinacol type ring of formula. in the presence of a metal catalyst.

The metal catalyst can be a palladium catalyst such as tetrakis(triphenylphosphine)- palladium(O), or tris(dibenzylideneacetone)dipalladium(0) in combination with a phosphine such as rac-BINAP or tri-ferf-butylphosphine. Preferably, the reaction is car- ried out in the presence of a base such as potassium carbonate or sodium tert- butoxide. The reaction can be carried out in an inert organic solvent such as toluene, or in mixtures of inert organic solvents and water, for example in mixtures of toluene and water. The reaction can be carried out at elevated temperatures, for example at a temperature from 70 to 200 °C, preferably at a temperature from 80 to 150 °C. The reac- tion mixture can be worked up by conventional methods.

If E is the ' c-bis(pinacolatoboryl) complex

is preferably used in the reaction.

This ' c-bis(pinacolatoboryl) complex can be synthesized via platinum catalyzed boro- nation of

R -FT

The compound of formula

wherein A 1 and A 2 are as defined above, R 41 , R 42 , R 43 , R 44 , R 45 and R 46 are Ci- 3 o-alkyl, preferably, Ci-20-alkyl, preferably Ci-6-alkyl, more preferably isopropyl, and Hal is halogen, preferably -Br, can be prepared by a process which comprises the step of reacting

wherein A 1 and A 2 are as defined above, and Hal is halogen, preferably -Br, with R 41 R 42 R 43 Si-Hal and R 44 R 45 R 46 Si-Hal and a base, wherein R 41 , R 42 , R 43 , R 44 , R 45 and R 46 are as defined above, and Hal is halogen, preferably -Br. An example of a base is lithium diisopropylamide. The reaction can be performed in an inert organic solvent, for example THF. The reaction can be performed at a temperature of 0 to -100 °C, preferably at -40 to -90 °C, preferably at around -78 °C. The reaction mixture obtained can be worked-up by conventional methods. The compound of formula

wherein A 1 and A 2 are as defined above, and Hal is halogen, preferably -Br, can be prepared by a process comprising the step of reacting wherein A 1 and A 2 are as defined above, with a halogenating agent.

An example of a halogenating agent is /V-bromosuccinimide. The reaction can be performed in an inert organic solvent, for example DMF. The reaction can be performed at elevated temperature, for example at a temperature from 20 to 100 °C, preferably at 40 to 80 °C. The reaction mixture obtained can be worked-up by conventional methods.

A compound of formula 2d can also be prepared via thiocyanation of 2,6-diamino- benzothiazole 18 as reported by Landquist, J. K. J. Chem. Soc. C 1967, 2212 to 2220, followed by Sandmeyer reaction as depicted below

18 2d

A compound of formula 2e can also be prepared via condensation of 3,6-diamino-1 ,2- phenylene dihydrogen thiosulphate 19 with thiophene-2-carboxylic acid in analogy to the processes described by Green, A.G. J. Chem. Soc, Trans. 1903, 83, 1201 to 1212, and by Cox, R.J.; Clecak, N.J. J. Org. Chem. 1968, 33, 2132 to 2133, followed by halogenation as depicted below

The compound of formula wherein A 1 and A 2 are as defined above, and Hal is halogen, preferably -Br, and E is selected from the group consisting of

wherein R 4 , R 5 , R 19 , R 20 and R 21 are as defined above, can be prepared by a process, which comprises the step of reacting a compound of formula

wherein A 1 and A 2 are as defined above, R 41 , R 42 , R 43 , R 44 , R 45 and R 46 are Ci- 3 o-alkyl, preferably Ci-6-alkyl, more preferably isopropyl, and Hal is halogen, preferably -Br, with a suitable compound to incorporate E, in the presence of a base such as butyl lithium.

For example, the compounds of formulae 2f, 2g, 2h and 2i can be prepared as follows

The compound of formula

wherein A 1 and A 2 are as defined above, and Hal is halogen, preferably -Br, and E is selected from the group consisting of

wherein R 4 , R 5 , R 19 , R 20 and R 21 are as defined above, can also be prepared by a process, which comprises the step of reacting a compound of formula wherein A 1 and A 2 are as defined above, R 41 , R 42 , R 43 , R 44 , R 45 and R 46 are Ci-3o-alkyl, preferably Ci-6-alkyl, more preferably isopropyl, with a suitable compound to incorporate E, in the presence of a base such as lithium diisopropylamide, for example as described for similar compounds in WO 2009/069687.

The compound of formula wherein A 1 and A 2 are as defined above, R 41 , R 42 , R 43 , R 44 , R 45 and R 46 are Ci- 3 o-alkyl, preferably Ci-6-alkyl, more preferably isopropyl, can be prepared via oxidative coupling of

For example the compound of formula 20a can be prepared as follows:

21a 20a

The compound of formula wherein

A 1 and A 2 can be the same or different and are S or Se,

E is selected from the group consisting of wherein

R 1 , R 2 , R 3 , R 4 , R 5 , R 19 , R2o and R 21 are as defined above, G 1 and G 2 are are as defined above, q and s are as defined above, and Hal is halogen, can be prepared by reacting the compound of formula wherein A 1 and A 2 are as defined above, and Hal is halogen, with suitable compounds to incorporate G 1 and G 2 , such as stannyl functionalized G 1 and G 2 or borate functionalized G 1 or G 2 or Grignard fuctionalized G 1 and G 2 , in the presence of a metal catalyst, followed by halogenation. For example, the compound of formula 8a can be prepared as follows:

Also part of the invention is the compound of formula wherein

A 1 and A 2 can be the same or different and are S or Se, E is selected from the group consisting of

wherein

R 1 , R 2 , R3, R 4 , R 5 , R 19 , R 20 and R 21 are as defined above and Hal is halogen.

Also part of the invention is the compound of formula

wherein

A 1 and A 2 can be the same or different and are S or Se, E is and R 41 , R 42 , R 43 , R 44 , R 45 and R 46 are Ci-3o-alkyl, preferably Ci- 6 -alkyl, more preferably isopropyl.

Also part of the invention is a compound of formula

wherein A 1 and A 2 can be the same or different and are S or Se,

R 41 , R 42 , R 43 , R 44 , R 45 and R 46 are Ci- 30 -alkyl, preferably Ci- 6 -alkyl, more preferably iso- propyl, and Hal is halogen, preferably -Br.

Also part of the present invention is an electronic device comprising the compounds, oligomers and polymers of the present invention.

The electronic device can be any electronic device, for example an organic photovoltaic (OPV) cell, an organic field-effect transistor (OFET) or an organic light emitting diode (OLED). Preferably, it is an organic field-effect transistor. The organc field effect transistor comprising the compounds, oligomers and polymers of the present invention can be prepared by solution deposition of a solution of the compounds, oligomers and polymers of the present invention in a suitable solvent. The solvent can be an organic solvent, for example 1 ,2-dichlorobenzene. Solution deposition can be performed by methods known in the art, for example by spin coating, for example at 2000 rpm, 255 acc (acc: spin acceleration), 1 minute.

The organic field effect transistor can have any architecture known in the art, for example a bottom gate bottom contact (BGBC) architecture as depicted in Figure 1. When the organic field effect transistor has a bottom gate bottom contact (BGBC) architec- ture, the substrate (or gate electrode), the gate dielectric, and the source and drain electrodes can be any substrate, gate dielectric, source and drain electrode known in the art. For example, the substrate (or gate electrode) can be heavily doped silicon wafer, the gate dielectric can be thermally grown silica, and the source and drain elec- trode can be made of gold which is lithographically patterned. Before deposition of the compounds, oligomers and polymers of the present invention as semiconductors, the device can be vapor treated with hexamethyldisilazane (HMDS). Also part of the invention is the use of the compound, oligomer or polymer of of the present invention as organic semiconducting material.

The compounds, oligomers and polymers of the present invention show a surprising high ioniziation potential, which may contribute to better ambient oxidative stability. The compounds, oligomers and polymers of the present invention are compatible with liquid processing techniques and are suitable for use as semiconductors in organic field effect transistors. The organic field effect transistor using the compounds, oligomers and polymers of the present invention as semiconductors show good field-effect mobilities and on/off ratios.

Figure 1 shows an organic field effect transistor having a bottom gate bottom contact (BGBC) architecture.

Examples Example 1

Preparation of 2,2'-dibromo-(5,6-dihexylbenzo[2,1-c/;3,4-c/]bisthiazole) (2a)

2a

Preparation of 4,4'-dibromo-5,5'-bithiazole (6a)

N-bromosuccinimide (6.35 g, 35.66 mmol, 4 eq.) is added to a stirred homogeneous solution of 5,5'-bithiazole (7a) (1 .5 g, 8.9 mmol) in anhydrous DMF (125 mL). The reaction mixture is heated at 60 °C for 3 hours. The reaction mixture is washed subsequently with an aqueous solution of 10% sodium bicarbonate (200 mL), extracted with dichloromethane (200 mL), washed with water (3 x 100 mL) and sodium chloride saturated water (100 mL), and dried over anhydrous sodium sulfate. The crude product is re-crystallized from dichloromethane/n-hexane (1 :10). Yellowish crystals are obtained. 1 H-NMR (d-chloroform) (400 MHz): δ 8.87 (s, 2H). 13 C-NMR (d-chloroform) (400 MHz): δ 154.8, 129.3, 122.5.

Preparation of 2,2'-bis(triisopropylsilyl)-4,4'-dibromo-5,5'-bithiazole (5a)

1 .84 mL of a 2M solution of lithium diisopropylamide (0.39 g, 3.68 mmol, 2.4 eq.) in THF is added dropwise to a solution of 4,4'-dibromo-5,5'-bithiazoles (6a) (0.5 g, 1.53 mmol) in anhydrous THF (20 mL) at -78 °C over 10 minutes. The reaction mixture is allowed to stir for 3 hours, and then triisopropylsilyl chloride (0.709 g, 0.79 mL, 3.68 mmol, 2.4 eq.) is added slowly. The reaction mixture is warmed up to room tempera- ture overnight. The reaction mixture is diluted with ethyl acetate (140 mL), and the organic layer is washed with sodium bicarbonate saturated water (70 mL) and sodium chloride saturated water (70 mL), dried over magnesium sulfate and concentrated in vacuo. Column chromatography using gradient solvent from n-hexane to ethyl ace- tate/n-hexane (5/95) provides a yellow solid. 1 H-NMR (d-chloroform) (400 MHz): δ 2.43 - 1.5 (m, J = 8 Hz, 6H), δ 1.16 - 1 .18 (d, J = 7.6 Hz, 36H). 13 C-N MR (d-chloroform) (400 MHz): δ 172.7, 130.5, 125.1 , 18.7, 1 1.8.

Preparation of 2,2'-bis(triisopropylsilyl)-(5,6-dihexylbenzo[2,1 -c/;3,4-c/]bisthiazole) (4a) A mixture of 5a (0.5 g, 0.783 mmol) and tetrakis(triphenylphosphine)palladium(0) (0.090 g, 0.078 mmol, 0.1 eq.) is degassed 3 times. A solution of ' c-bis(pinacolato- boryl)-7-tetradecene (0.456 g, 1 .018 mmol, 1 .3 eq.), in anhydrous toluene (5 mL) is added, followed by 12 mL of toluene (total 17 mL anhydrous toluene). Subsequently 2.8 mL of degassed aqueous solution of potassium carbonate (0.64 g, 4.70 mmol, 6 eq.) is added. The reaction mixture is stirred and heated at 100 °C overnight. The reaction mixture is allowed to cool to room temperature, and is diluted with ethyl acetate (50 mL). The resulting reaction mixture is washed with ammonium chloride saturated water (50 mL) and the aqueous layer is extracted with ethyl acetate (3 x 50 mL). The combined organic layers are washed with sodium chloride saturated water (25 mL), dried over magnesium sulfate, and concentrated in vacuo. Column chroma- tography using a gradient solvent from n-hexane to ethyl acetate/n-hexane (10/90) provides an off-white solid. 1 H-NMR (d-chloroform) (400 MHz): δ 3.37 (dd, J = 8 Hz, 4H), δ 1.74 - 1 .76 (m, J = 8 Hz, 4H), δ 1.47 - 1 .55 (m, J = 8 Hz, 6H), δ 1 .33 - 1 .37 (m, J = 8 Hz, 12H), δ 1 .2 - 1 .22 (d, J = 8 Hz, 36H), δ 0.87 - 0.92 (t, J = 7.6 Hz, 6H). LC-MS: 95% purity with m/z 673.4.

Preparation of 2,2'-dibromo-(5,6-dihexylbenzo[2, 1 -c/;3,4-c/]bisthiazole) (2a)

A solution of bromine (0.34 g, 0.1 1 mL, 2.1 1 mmol, 4 eq.) in chloroform (5 mL) containing trichloroacetic acid (7 mg) is added dropwise and slowly to a solution of 4a (0.355 g, 0.527 mmol) in chloroform (8 mL) at 0 °C. The reaction mixture is stirred at room temperature for 3 days. The reaction mixture is diluted with dichloromethane (50 mL), washed with an aqueous solution of 20 weight% sodium thiosulfate (50 mL) and with an aqueous solution of 10 weight% sodium bicarbonate (50 mL). Subsequently the organic layer is dried over magnesium sulfate and concentrated in vacuo. Purification by column chromatography (ethyl acetate/n-hexane (10/90)) followed by re-crystallisation from ethanol affords light brown crystals. 1 H-NMR (d-chloroform) (400 MHz): δ 3.17 (dd, J = 8 Hz, 4H), δ 1.66 (m, J = 8 Hz, 4H), δ 1 .47 (m, J = 8 Hz, 4H), δ 1 .35 (m, J = 8 Hz, 8H), δ 0.92 (t, J = 7.6 Hz, 6H). LC-MS: 98% purity with m/z 519. Elemental analysis (calcd): C, 46.34 (46.36); H, 5.06 (5.09).

Example 2

Preparation of poly(benzobisthiazole-cyclopentadithiophene) (1 a)

1a Dibromo-benzobisthiazole (2a) (60 mg, 0.1 16 mmol, 1 eq.), bis(trimethylstannyl)- cyclopentadithiophene (3a) (1 10 mg, 0.1 16 mmol, 1 eq.), tris(dibenzylidene- acetone)dipalladium(O) (3.2 mg, 0.003 mmol, 3% eq.) and tri-o-tolylphosphine (2.1 mg, 0.007 mmol, 6% eq.) are added into a Schlenk flask and degassed 3 times. Chlorobenzene (4 mL) is added and the reaction mixture is stirred at 100 °C overnight then at 130 °C for 2 days. 2-Bromothiophene (0.01 mL) and 2-tributylstannylthiophene

(0.01 mL) are added as end cappers, with 2-bromothiophene added first followed by 2-tributylstannylthiophene 2 hours later. After another 2 hours stirring, the reaction mixture is cooled to room temperature. The reaction mixture is then added dropwise to methanol (200 mL), filtered, and then subjected to Soxhiet extraction with acetone. The polymer is recovered as solid mass and showed Mn = 8360 g/mol (Mw = 24264 g/mol & PDI = 2.92). Elemental analysis (calcd): C, 70.77 (74.48); H, 8.93 (9.63).

Example 3

Preparation of poly(benzobisthiazole-bisthienylethylene) (1 b)

Dibromo-benzobisthiazole (2a) (55 mg, 0.106 mmol, 1 eq.) prepared as described in example 1 , bis(2-trimethylstannyl-4-dodecylthienyl)ethylene (3b) (90.7 mg, 0.106 mmol, 1 eq.), tris(dibenzylideneacetone)dipalladium(0) (2.9 mg, 0.003 mmol, 3% eq.) and tri- o-tolylphosphine (1.9 mg, 0.006 mmol, 6% eq.) are added into a Schlenk flask and degassed 3 times. Chlorobenzene (2 mL) is added and the reaction mixture is stirred at 130 °C for 2 days. 2-Bromothiophene (0.01 mL) and 2-tributylstannylthiophene

(0.01 mL) are added as end cappers, with 2-bromothiophene added first followed by 2-tributylstannylthiophene 2 hours later. After another 2 hours stirring, the reaction mixture is cooled to room temperature. The mixture is filtered and the filtrate is concentrated and added dropwise to methanol (200 mL), filtered, and then subjected to Soxhiet extraction with acetone. The polymer is recovered as solid mass and showed Mn = 3368 g/mol (Mw = 4749 g/mol & D = 1.41 ).

Example 4

Preparation of poly(benzobisthiazole-bithiophene) (1c)

Preparation of 2,2'-dibromo-(5,6-dimethylbenzo[2,1 -c/;3,4-c/]bisthiazole) (2b)

Dibromo-benzobisthiazole (2b) is prepared in analogy to 2,2'-dibromo-(5,6-dihexyl- benzo[2,1 -d;3,4-d]bisthiazole) (2a) in example 1 , except that ' c-bis(pinacolatoboryl)- 2-butene (with the equivalent of 1.3 eq to the substrate 5a) is used instead of ' c-bis- (pinacolatoboryl)-7-tetradecene (with the equivalent of 1 .3 eq to the substrate 5a).

Preparation of poly(benzobisthiazole-bithiophene) (1 c)

Dibromo-benzobisthiazole (2b) (79 mg, 0.209 mmol, 1 eq.) is added as a 4.2 ml_ chlorobenzene solution into a pre-degassed mixture of bis(2-trimethylstannyl-2-do- decylthiophene) (3c) (173.1 mg, 0.209 mmol, 1 eq.), tris(dibenzylideneacetone)- dipalladium(O) (5.7 mg, 0.003 mmol, 3% eq.) and tri-o-tolylphosphine (3.8 mg,

0.006 mmol, 6% eq.). The reaction mixture is stirred at 130 °C for 2 days. After two days of reaction, tris(dibenzylideneacetone)-dipalladium(0) (5.7 mg, 0.003 mmol, 3% eq.) and tri-o-tolylphosphine (3.8 mg, 0.006 mmol, 6% eq.) is added. After four days of reaction, another portion of tris(dibenzylidene-acetone)dipalladium(0) (5.7 mg, 0.003 mmol, 3% eq.) and tri-o-tolylphosphine (3.8 mg, 0.006 mmol, 6% eq.) is added. After total 6 days, the polymerization is stopped by the addition of 2-bromothiophene (0.01 ml.) and 2-tributylstannylthiophene (0.01 ml_). 2-Bromothiophene is added first followed by 2-tributylstannylthiophene 4 hours later. After another 24 hours stirring, the reaction mixture is cooled to room temperature. The mixture is filtered and the filtrate is concentrated and added dropwise to a methanolic solution of 5 weight% HCI (200 ml_). The polymer is filtered and before soxhlet extraction in acetone showed Mn = 959 g/mol (Mw = 1410 g/mol & D = 1 .47).

Example 5

Preparation of A/-4-decylaniline-2,6-dibromo dithiazolo[2,3-d;,3',2'-£>]pyrrole (2c)

2c

Preparation of /V-4-decylaniline-2,6-bis(triisoproylsilyl) dithiazolo[2,3-c/;3',2'-£>] pyrrole) (4b)

A mixture of bis(triisopropylsilyl)-dibromobithiazole (5a) (790 mg, 1 .237 mmol), tris(di- benzylideneacetone)dipalladium(O) (1 13 mg, 0.123 mmol, 0.1 eq.), sodium ferf-but- oxide (200 mg, 2.968 mmol, 2.4 eq.) and rac-BINAP (153 mg, 0.347 mmol, 0.2 eq.) is degassed 3 times. 4-n-Decylaniline (360 mg, 1 .546 mmol, 1 .25 eq.) in anhydrous toluene (18 mL) is added. The reaction mixture is stirred and heated at 100 °C for 2 days under nitrogen. After the mono-aminated intermediate is formed tris(dibenzylidene- acetone)dipalladium(O) (56 mg, 0.061 mmol, 0.05 eq.) and 0.36 mL of a 10 weight% solution of tri-ferf-butylphosphine (24 mg, 0.173 mmol, 0.1 eq.) in n-hexane is added. The reaction mixture is stirred at 100 °C for 2 days under nitrogen. Afterwards the reaction mixture is diluted with ethyl acetate (100 mL). The resulting reaction mixture is washed with ammonium chloride saturated water (100 mL) and the aqueous layer is extracted with ethyl acetate (3 x 70 mL). The combined organic layers are washed with sodium chloride saturated water (50 mL), dried over magnesium sulfate, and concentrated in vacuo. Column chromatography using ethyl acetate/n-hexane (2/98) provided off-white solid. 1 H-NMR (d-chloroform) (400 MHz): δ 8.58 (d, J = 9.6 Hz, 2H), δ 7.34 (d, J = 8.4 Hz, 2H), δ 2.28 (dd, J = 8 Hz, 2H), δ 1 .65 (m, J = 8 Hz, 2H), δ 1.52 - 1.46 (m, J = 8 Hz, 6H), δ 1 .27 (s, 14H), δ 1 .19 - 1 .21 (d, J = 8 Hz, 36H), δ 0.88 (t, J = 7.6 Hz, 3H).

Preparation of A/-4-decylaniline-2,6-dibromo dithiazolo[2,3-c/;,3',2'-£>]pyrrole (2c) A solution of bromine (0.16 g, 0.05 mL, 1 .01 mmol, 4 eq.) in chloroform (3 mL) containing trichloroacetic acid (4 mg) is slowly and dropwise added to a solution of 4b

(0.180 g, 0.253 mmol) in chloroform (4 mL) at 0 °C. The reaction mixture is stirred at room temperature for 2 days. The reaction mixture is diluted with dichloromethane (50 mL), washed with an aqueous solution of 20 weight% sodium thiosulfate (50 mL) and an aqueous solution of 10 weight% sodium bicarbonate (50 mL). Subsequently the organic layer is dried over magnesium sulfate and concentrated in vacuo. Purification by column chromatography using n-hexane followed by re-crystallisation from n-hexane affords white flakes. 1 H-NMR (d-chloroform) (400 MHz): δ 7.88 (d, J = 8.4 Hz, 2H), δ 7.35 (d, J = 8 Hz, 2Η),δ 2.66 (dd, J = 7.6 Hz, 2H), δ 1 .63 (m, J = 7.6 Hz, 2H), δ 1 .28 (s, 14H), δ 0.88 (t, J = 7.6 Hz, 3H). LC-MS: 97.2% purity with m/z 556. Elemental analysis (calcd): C, 47.54 (47.58); H, 4.46 (4.54).

Example 6

Preparation of poly(dithiazolopyrrole-bisthienylethylene) (1 d)

Dibromo-dithiazolopyrrole (2c) (36 mg, 0.065 mmol, 1 eq.) prepared as described in example 5, bis(2-trimethylstannyl-4-dodecylthienyl)ethylene (3d) (55.4 mg, 0.065 mmol, 1 eq.), tris(dibenzylideneacetone)dipalladium(0) (3.6 mg, 0.004 mmol, 6% eq.) and tri- o-tolylphosphine (2.4 mg, 0.008 mmol, 12% eq.) are added into a Schlenk flask and degassed 3 times. Chlorobenzene (1 .5 mL) is added and the reaction mixture is stirred at 130 °C for 2 days. After two days of reaction, tris(dibenzylideneacetone)dipalla- dium(0) (3.6 mg, 0.004 mmol, 6% eq.) and tri-o-tolylphosphine (2.4 mg, 0.008 mmol, 12% eq.) was added. After total reaction of 3 days, the polymerization is stopped by the addition of 2-bromothiophene (0.01 mL) followed by 2-tributylstannylthiophene

(0.01 mL) 3 hours later. After another 3 hours stirring, the reaction mixture is cooled to room temperature and added dropwise to methanol (100 mL), filtered, and then subjected to Soxhlet extraction with acetone. The polymer is recovered as solid mass and showed Mn = 4305 g/mol (Mw = 7571 g/mol & D = 1 .76).

Measurement of the Ionization Potential of Polymer 1 a

The oxidative stability of π-conjugated polymers may be contributed by their ionization potential (IP), that is, on the energy of the highest occupied molecular orbital (HOMO) with respect to vacuum. The ionization potential (IP) is also reflected as negative value of the HOMO energy level (EHOMO) of a molecule, oligomer or polymer,

IP = - EHOMO and can be measured by cyclic voltammetry (CV). The HOMO energy levels (EHOMO) of poly(benzobisthiazole-cyclopentadithiophene) (1 a), prepared as described in example 2, and comparative polymer 22a, which is described by Xiao, S; Zhou H.; You, W. in Macromolecules 2008, 41, 5688-5696, are determined by cyclic voltammetry (CV).

1a 22a

Cyclic voltamogramms are recorded from thin films of polymer 1 a, respectively comparative polymer 22a, drop-casted from 0.5 mg/mL chloroform solutions. A Pt disk is used as a working electrode and Ag/AgCI reference electrode is employed. The meas- urement is done in tetrabutylammonium tetrafluoroborate as electrolyte and ferro- cene/ferrocenium redox couple (Fc/Fc + ) is used as an internal reference, which has a known reduction potential of 4.8 eV. The electrochemical (oxidation and reduction) onset is determined at the position where the current starts to differ from the baseline and the HOMO energy level (EHOMO) is calculated from the onset oxidation potential (Eox), as shown in the equation below: EHOMO = -(Eox + 4.8) [eV]

The results are outlined in table 1.

Table 1 .

As can be derived from table 1 , the HOMO energy level (EHOMO) value of polymer 1 a is decreased by 0.4 eV compared to the HOMO energy level (EHOMO) value of comparative polymer 22a, and thus the ionization potential (IP) and consequently the oxidative stability of polymer 1 a is higher than the one of comparative polymer 22a.

Fabrication of an Organic Field-Effect Transistor using Polymer 1 a as Semiconductor An organic field effect transistor is made in bottom gate bottom contact (BGBC) architecture, as depicted in Figure 1 . Heavily doped Si wafer are used as substrate and gate electrode with 200 nm thermally grown S1O2 serving as gate dielectric. Source and drain electrode are made of gold which is lithographically patterned. Before semiconductor deposition, the substrate is vapor treated with hexamethyldisilazane (HMDS). The polymer 1 a solution is prepared by solubilizing the polymer 1 a in 1 ,2-dichloro- benzene and heating it inside oven until soluble. Subsequently, semiconductor solution deposition of the polymer 1 a is done by spin coating (deposition condition: 2000 rpm, 255 acc, 1 minute). The organic field effect transitor is made in ambient environment.

Testing of the Organic Field-Effect Transistor using Polymer 1a as Semiconductor

The hole mobility (μ ρ ), onset voltage (V on , voltage when the drain current increases abruptly and can be measured), and the on/off ratio of the organic field effect transitor using polymer 1 a as semiconductor are determined at room temperature and after an- nealing at 200 °C for 30 minutes, in order to observe the effect of annealing on the semiconductor performance. The organic field effect transitor is tested in ambient environment. Channel length (L) = 5 μΐη, Channel width (W) = 350 μΐη, W/L = 70. Measurement is performed at: gate voltage (Vg) = sweep from 20 to -90 V, drain voltage (Vd) = -90 V,

The results are outlined in table 2. hole mobility

μ ρ [cm 2 /Vs] Von[V] On/Off ratio

at RT 0.2 x I O- 3 -5 2.66 x 10 4

after annealing at 200 °C 1 .06 x I O- 3 5 6.01 x 10 4 Table 2.